{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:57:54Z","timestamp":1787731074446,"version":"build-2784847793"},"reference-count":298,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04589-4","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T02:02:00Z","timestamp":1730426520000},"page":"4802-4836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications"],"prefix":"10.1007","volume":"62","author":[{"given":"Samir Kumar","family":"Beura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Ramachandra","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh P.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"issue":"3","key":"4589_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R et al (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23(3):1851. https:\/\/doi.org\/10.3390\/ijms23031851","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4589_CR2","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9(7):a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4589_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"key":"4589_CR4","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.arr.2024.102205","volume":"94","author":"SK Beura","year":"2024","unstructured":"Beura SK, Panigrahi AR, Yadav P et al (2024) Harnessing two-dimensional nanomaterials for diagnosis and therapy in neurodegenerative diseases: advances, challenges and prospects. Ageing Res Rev 94:102205. https:\/\/doi.org\/10.1016\/j.arr.2024.102205","journal-title":"Ageing Res Rev"},{"issue":"6","key":"4589_CR5","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/med.21965","volume":"43","author":"SK Beura","year":"2023","unstructured":"Beura SK, Dhapola R, Panigrahi AR et al (2023) Antiplatelet drugs: potential therapeutic options for the management of neurodegenerative diseases. Med Res Rev 43(6):1835\u20131877. https:\/\/doi.org\/10.1002\/med.21965","journal-title":"Med Res Rev"},{"key":"4589_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.2006.01687.x","volume":"260","author":"MJ Stampfer","year":"2006","unstructured":"Stampfer MJ (2006) Cardiovascular disease and Alzheimer\u2019s disease: common links. J Intern Med 260:211\u2013223. https:\/\/doi.org\/10.1111\/j.1365-2796.2006.01687.x","journal-title":"J Intern Med"},{"key":"4589_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mds.27836","volume":"35","author":"J Potashkin","year":"2020","unstructured":"Potashkin J, Huang X, Becker C et al (2020) Understanding the links between cardiovascular disease and Parkinson\u2019s disease. Mov Disord 35:55\u201374. https:\/\/doi.org\/10.1002\/mds.27836","journal-title":"Mov Disord"},{"key":"4589_CR8","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.33549\/physiolres.935109","volume":"72","author":"J Kune\u0161","year":"2023","unstructured":"Kune\u0161 J, Hojn\u00e1 S, Mr\u00e1zikov\u00e1 L et al (2023) Obesity, cardiovascular and neurodegenerative diseases: potential common mechanisms. Physiol Res 72:S73\u2013S90. https:\/\/doi.org\/10.33549\/physiolres.935109","journal-title":"Physiol Res"},{"key":"4589_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","volume":"124","author":"JM Tublin","year":"2019","unstructured":"Tublin JM, Adelstein JM, Del Monte F et al (2019) Getting to the heart of Alzheimer disease. Circ Res 124:142\u2013149. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313563","journal-title":"Circ Res"},{"key":"4589_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2009.136","volume":"5","author":"W Nanhoe-Mahabier","year":"2009","unstructured":"Nanhoe-Mahabier W, de Laat KF, Visser JE et al (2009) Parkinson disease and comorbid cerebrovascular disease. Nat Rev Neurol 5:533\u2013541. https:\/\/doi.org\/10.1038\/nrneurol.2009.136","journal-title":"Nat Rev Neurol"},{"key":"4589_CR11","doi-asserted-by":"publisher","first-page":"103279","DOI":"10.1016\/j.msard.2021.103279","volume":"56","author":"D Rapp","year":"2021","unstructured":"Rapp D, Michels S, Sch\u00f6pe J et al (2021) Associations between multiple sclerosis and incidence of heart diseases: systematic review and meta-analysis of observational studies. Mult Scler Relat Disord 56:103279. https:\/\/doi.org\/10.1016\/j.msard.2021.103279","journal-title":"Mult Scler Relat Disord"},{"key":"4589_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fphys.2018.00559","volume":"9","author":"BJ Critchley","year":"2018","unstructured":"Critchley BJ, Isalan M, Mielcarek M (2018) Neuro-cardio mechanisms in Huntington\u2019s disease and other neurodegenerative disorders. Front Physiol 9:559. https:\/\/doi.org\/10.3389\/fphys.2018.00559","journal-title":"Front Physiol"},{"key":"4589_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark K, Massberg S (2021) Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 18:666\u2013682. https:\/\/doi.org\/10.1038\/s41569-021-00552-1","journal-title":"Nat Rev Cardiol"},{"key":"4589_CR14","doi-asserted-by":"publisher","first-page":"843404","DOI":"10.3389\/fimmu.2022.843404","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Langer HF (2022) Platelets, thromboinflammation and neurovascular disease. Front Immunol 13:843404. https:\/\/doi.org\/10.3389\/fimmu.2022.843404","journal-title":"Front Immunol"},{"key":"4589_CR15","first-page":"87","volume":"4","author":"KT Thakur","year":"2016","unstructured":"Thakur KT, Albanese E, Giannakopoulos P et al (2016) Neurological disorders. Dis Control Priorities 4:87\u2013107","journal-title":"Dis Control Priorities"},{"key":"4589_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3389\/fnins.2019.00728","volume":"13","author":"X Castillo","year":"2019","unstructured":"Castillo X, Castro-Obreg\u00f3n S, Guti\u00e9rrez-Becker B et al (2019) Re-thinking the etiological framework of neurodegeneration. Front Neurosci 13:728. https:\/\/doi.org\/10.3389\/fnins.2019.00728","journal-title":"Front Neurosci"},{"key":"4589_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VM-Y, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151\u2013170. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100113","journal-title":"Annu Rev Pathol"},{"key":"4589_CR18","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1038\/nature16031","volume":"527","author":"GL Birbeck","year":"2015","unstructured":"Birbeck GL, Meyer A-C, Ogunniyi A (2015) Nervous system disorders across the life course in resource-limited settings. Nature 527:S167\u2013S171. https:\/\/doi.org\/10.1038\/nature16031","journal-title":"Nature"},{"key":"4589_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nj7526-299a","volume":"515","author":"K Gammon","year":"2014","unstructured":"Gammon K (2014) Neurodegenerative disease: brain windfall. Nature 515:299\u2013300. https:\/\/doi.org\/10.1038\/nj7526-299a","journal-title":"Nature"},{"key":"4589_CR20","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41467-022-31873-5","volume":"13","author":"TS Wingo","year":"2022","unstructured":"Wingo TS, Liu Y, Gerasimov ES et al (2022) Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat Commun 13:4314. https:\/\/doi.org\/10.1038\/s41467-022-31873-5","journal-title":"Nat Commun"},{"issue":"7","key":"4589_CR21","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/ijms24076354","volume":"24","author":"A Bianco","year":"2023","unstructured":"Bianco A, Antonacci Y, Liguori M (2023) Sex and gender differences in neurodegenerative diseases: challenges for therapeutic opportunities. Int J Mol Sci 24(7):6354. https:\/\/doi.org\/10.3390\/ijms24076354","journal-title":"Int J Mol Sci"},{"key":"4589_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mdc3.13178","volume":"8","author":"S Hentosh","year":"2021","unstructured":"Hentosh S, Zhu L, Patino J et al (2021) Sex differences in Huntington\u2019s disease: evaluating the Enroll-HD Database. Mov Disord Clin Pract 8:420\u2013426. https:\/\/doi.org\/10.1002\/mdc3.13178","journal-title":"Mov Disord Clin Pract"},{"key":"4589_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/fn.2020.96707","volume":"58","author":"R Armstrong","year":"2020","unstructured":"Armstrong R (2020) What causes neurodegenerative disease? Folia Neuropathol 58:93\u2013112. https:\/\/doi.org\/10.5114\/fn.2020.96707","journal-title":"Folia Neuropathol"},{"issue":"1","key":"4589_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K et al (2015) Alzheimer\u2019s disease. Nat Rev Dis Prim 1(1):1\u201318. https:\/\/doi.org\/10.1038\/nrdp.2015.56","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"4589_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC et al (2021) Alzheimer disease. Nat Rev Dis Prim 7(1):1\u201321. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Prim"},{"key":"4589_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/diseases12060110","volume":"12","author":"CA Valdez-Gaxiola","year":"2024","unstructured":"Valdez-Gaxiola CA, Rosales-Leycegui F, Gaxiola-Rubio A et al (2024) Early- and late-onset Alzheimer\u2019s disease: two sides of the same coin? Diseases 12:110. https:\/\/doi.org\/10.3390\/diseases12060110","journal-title":"Diseases"},{"key":"4589_CR27","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1038\/s41598-019-44848-2","volume":"9","author":"GV Van","year":"2019","unstructured":"Van GV, Bagyinszky E, Yang YS et al (2019) Genetic analyses of early-onset Alzheimer\u2019s disease using next generation sequencing. Sci Rep 9:8368. https:\/\/doi.org\/10.1038\/s41598-019-44848-2","journal-title":"Sci Rep"},{"key":"4589_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"4589_CR29","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"1","key":"4589_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F et al (2018) Multiple sclerosis. Nat Rev Dis Prim 4(1):1\u201327. https:\/\/doi.org\/10.1038\/s41572-018-0041-4","journal-title":"Nat Rev Dis Prim"},{"issue":"12","key":"4589_CR31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M et al (2022) The immunology of multiple sclerosis. Nat Rev Immunol 22(12):734\u2013750. https:\/\/doi.org\/10.1038\/s41577-022-00718-z","journal-title":"Nat Rev Immunol"},{"key":"4589_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"4589_CR33","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF et al (2015) Huntington disease. Nat Rev Dis Prim 1:15005. https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Nat Rev Dis Prim"},{"key":"4589_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","volume":"16","author":"J Brettschneider","year":"2015","unstructured":"Brettschneider J, Del Tredici K, Lee VM-Y, Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16:109\u2013120. https:\/\/doi.org\/10.1038\/nrn3887","journal-title":"Nat Rev Neurosci"},{"key":"4589_CR35","doi-asserted-by":"publisher","first-page":"e202300225","DOI":"10.1002\/slct.202300225","volume":"8","author":"S Zaib","year":"2023","unstructured":"Zaib S, Javed H, Khan I et al (2023) Neurodegenerative diseases: their onset, epidemiology, causes and treatment. ChemistrySelect 8:e202300225. https:\/\/doi.org\/10.1002\/slct.202300225","journal-title":"ChemistrySelect"},{"key":"4589_CR36","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.smim.2022.101628","volume":"59","author":"G Tesco","year":"2022","unstructured":"Tesco G, Lomoio S (2022) Pathophysiology of neurodegenerative diseases: an interplay among axonal transport failure, oxidative stress, and inflammation? Semin Immunol 59:101628. https:\/\/doi.org\/10.1016\/j.smim.2022.101628","journal-title":"Semin Immunol"},{"key":"4589_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"4589_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183\u2013193. https:\/\/doi.org\/10.1016\/S1474-4422(14)70256-X","journal-title":"Lancet Neurol"},{"key":"4589_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16:529\u2013546. https:\/\/doi.org\/10.1038\/s41582-020-0389-4","journal-title":"Nat Rev Neurol"},{"key":"4589_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jagp.2020.07.011","volume":"29","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. Am J Geriatr Psychiatry 29:375\u2013383. https:\/\/doi.org\/10.1016\/j.jagp.2020.07.011","journal-title":"Am J Geriatr Psychiatry"},{"key":"4589_CR41","doi-asserted-by":"publisher","first-page":"1071820","DOI":"10.3389\/fcvm.2023.1071820","volume":"10","author":"L Sha","year":"2023","unstructured":"Sha L, Li Y, Zhang Y et al (2023) Heart-brain axis: association of congenital heart abnormality and brain diseases. Front Cardiovasc Med 10:1071820. https:\/\/doi.org\/10.3389\/fcvm.2023.1071820","journal-title":"Front Cardiovasc Med"},{"key":"4589_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00335-022-09974-9","volume":"34","author":"L Garrett","year":"2023","unstructured":"Garrett L, Tr\u00fcmbach D, Spielmann N et al (2023) A rationale for considering heart\/brain axis control in neuropsychiatric disease. Mamm Genome 34:331\u2013350. https:\/\/doi.org\/10.1007\/s00335-022-09974-9","journal-title":"Mamm Genome"},{"key":"4589_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/CIRCRESAHA.116.308446","volume":"120","author":"P Tahsili-Fahadan","year":"2017","unstructured":"Tahsili-Fahadan P, Geocadin RG (2017) Heart-brain axis: effects of neurologic injury on cardiovascular function. Circ Res 120:559\u2013572. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308446","journal-title":"Circ Res"},{"key":"4589_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","volume":"118","author":"B Olshansky","year":"2008","unstructured":"Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863\u2013871. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.760405","journal-title":"Circulation"},{"key":"4589_CR45","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","volume":"54","author":"F Triposkiadis","year":"2009","unstructured":"Triposkiadis F, Karayannis G, Giamouzis G et al (2009) The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54:1747\u20131762. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.015","journal-title":"J Am Coll Cardiol"},{"key":"4589_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4899688","volume":"2021","author":"C Xu","year":"2021","unstructured":"Xu C, Tao X, Ma X et al (2021) Cognitive dysfunction after heart disease: a manifestation of the heart-brain axis. Oxid Med Cell Longev 2021:1\u201310. https:\/\/doi.org\/10.1155\/2021\/4899688","journal-title":"Oxid Med Cell Longev"},{"key":"4589_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/CLEP.S30621","volume":"5","author":"A Hakim","year":"2013","unstructured":"Hakim A, Ng Turek (2013) Heart disease as a risk factor for dementia. Clin Epidemiol 5:135\u2013145. https:\/\/doi.org\/10.2147\/CLEP.S30621","journal-title":"Clin Epidemiol"},{"key":"4589_CR48","doi-asserted-by":"publisher","first-page":"e12034","DOI":"10.1002\/trc2.12034","volume":"6","author":"AE Leeuwis","year":"2020","unstructured":"Leeuwis AE, Hooghiemstra AM, Bron EE et al (2020) Cerebral blood flow and cognitive functioning in patients with disorders along the heart-brain axis: cerebral blood flow and the heart-brain axis. Alzheimers Dement (N Y) 6:e12034. https:\/\/doi.org\/10.1002\/trc2.12034","journal-title":"Alzheimers Dement (N Y)"},{"key":"4589_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1742-1241.2003.tb10437.x","volume":"57","author":"A Gupta","year":"2003","unstructured":"Gupta A, Pansari K (2003) The association between blood coagulation markers, atherothrombosis and dementia. Int J Clin Pract 57:107\u2013111. https:\/\/doi.org\/10.1111\/j.1742-1241.2003.tb10437.x","journal-title":"Int J Clin Pract"},{"key":"4589_CR50","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A et al (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21:1318\u20131331. https:\/\/doi.org\/10.1038\/s41593-018-0234-x","journal-title":"Nat Neurosci"},{"key":"4589_CR51","doi-asserted-by":"publisher","first-page":"557384","DOI":"10.3389\/fnagi.2020.557384","volume":"12","author":"C Watanabe","year":"2020","unstructured":"Watanabe C, Imaizumi T, Kawai H et al (2020) Aging of the vascular system and neural diseases. Front Aging Neurosci 12:557384. https:\/\/doi.org\/10.3389\/fnagi.2020.557384","journal-title":"Front Aging Neurosci"},{"key":"4589_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.dadm.2017.01.002","volume":"7","author":"LR Clark","year":"2017","unstructured":"Clark LR, Berman SE, Rivera-Rivera LA et al (2017) Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer\u2019s disease. Alzheimer\u2019s Demen: Diagn Assess Dis Monit 7:48\u201355. https:\/\/doi.org\/10.1016\/j.dadm.2017.01.002","journal-title":"Alzheimer\u2019s Demen: Diagn Assess Dis Monit"},{"key":"4589_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-94-017-1007-7_4","volume-title":"Cerebral amyloid angiopathy in Alzheimer\u2019s disease and related disorders","author":"HV Vinters","year":"2000","unstructured":"Vinters HV (2000) Cerebral microvascular and macrovascular disease in the aging brain; similarities and differences. Cerebral amyloid angiopathy in Alzheimer\u2019s disease and related disorders. Springer, Netherlands, Dordrecht, pp 59\u201378"},{"key":"4589_CR54","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","volume":"4","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Skoog I, Schneider JA et al (2018) Vascular cognitive impairment. Nat Rev Dis Primers 4:18003. https:\/\/doi.org\/10.1038\/nrdp.2018.3","journal-title":"Nat Rev Dis Primers"},{"key":"4589_CR55","doi-asserted-by":"publisher","first-page":"120855","DOI":"10.1016\/j.lfs.2022.120855","volume":"306","author":"SK Beura","year":"2022","unstructured":"Beura SK, Dhapola R, Panigrahi AR et al (2022) Redefining oxidative stress in Alzheimer\u2019s disease: targeting platelet reactive oxygen species for novel therapeutic options. Life Sci 306:120855. https:\/\/doi.org\/10.1016\/j.lfs.2022.120855","journal-title":"Life Sci"},{"key":"4589_CR56","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1532-5415.2005.53360.x","volume":"53","author":"AB Newman","year":"2005","unstructured":"Newman AB, Fitzpatrick AL, Lopez O et al (2005) Dementia and Alzheimer\u2019s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53:1101\u20131107. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53360.x","journal-title":"J Am Geriatr Soc"},{"key":"4589_CR57","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","volume":"141","author":"J-H Park","year":"2020","unstructured":"Park J-H, Kim D-H, Park Y-G et al (2020) Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality: a nationwide, population-based cohort study. Circulation 141:1205\u20131207","journal-title":"Circulation"},{"key":"4589_CR58","doi-asserted-by":"publisher","first-page":"101681","DOI":"10.1016\/j.arr.2022.101681","volume":"80","author":"SK Beura","year":"2022","unstructured":"Beura SK, Panigrahi AR, Yadav P, Singh SK (2022) Role of platelet in Parkinson\u2019s disease: insights into pathophysiology & theranostic solutions. Ageing Res Rev 80:101681. https:\/\/doi.org\/10.1016\/j.arr.2022.101681","journal-title":"Ageing Res Rev"},{"key":"4589_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/br.2023.1607","volume":"18","author":"L Grosu","year":"2023","unstructured":"Grosu L, Grosu AI, Crisan D et al (2023) Parkinson\u2019s disease and cardiovascular involvement: edifying insights. Biomed Rep 18:1\u20138","journal-title":"Biomed Rep"},{"key":"4589_CR60","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1093\/brain\/awaa255","volume":"143","author":"R Geraldes","year":"2020","unstructured":"Geraldes R, Esiri MM, Perera R et al (2020) Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships. Brain 143:2998\u20133012. https:\/\/doi.org\/10.1093\/brain\/awaa255","journal-title":"Brain"},{"key":"4589_CR61","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1352458514564485","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J et al (2015) A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler 21:318\u2013331. https:\/\/doi.org\/10.1177\/1352458514564485","journal-title":"Mult Scler"},{"key":"4589_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jocn.2021.12.021","volume":"96","author":"K Xu","year":"2022","unstructured":"Xu K, Ji H, Hu N (2022) Cardiovascular comorbidities in amyotrophic lateral sclerosis: a systematic review. J Clin Neurosci 96:43\u201349. https:\/\/doi.org\/10.1016\/j.jocn.2021.12.021","journal-title":"J Clin Neurosci"},{"key":"4589_CR63","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.2174\/1381612825666190925163827","volume":"25","author":"GD Flora","year":"2019","unstructured":"Flora GD, Nayak MK (2019) A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des 25:4063\u20134084. https:\/\/doi.org\/10.2174\/1381612825666190925163827","journal-title":"Curr Pharm Des"},{"key":"4589_CR64","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P (2021) The changing landscape of atherosclerosis. Nature 592:524\u2013533. https:\/\/doi.org\/10.1038\/s41586-021-03392-8","journal-title":"Nature"},{"issue":"5","key":"4589_CR65","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/ijms19051299","volume":"19","author":"C Tana","year":"2018","unstructured":"Tana C, Lauretani F, Ticinesi A et al (2018) Molecular and clinical issues about the risk of venous thromboembolism in older patients: a focus on Parkinson\u2019s disease and Parkinsonism. Int J Mol Sci 19(5):1299. https:\/\/doi.org\/10.3390\/ijms19051299","journal-title":"Int J Mol Sci"},{"key":"4589_CR66","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/eurheartj\/ehw550","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38:785\u2013791. https:\/\/doi.org\/10.1093\/eurheartj\/ehw550","journal-title":"Eur Heart J"},{"key":"4589_CR67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/JAD-2012-120820","volume":"32","author":"M Cortes-Canteli","year":"2012","unstructured":"Cortes-Canteli M, Zamolodchikov D, Ahn HJ et al (2012) Fibrinogen and altered hemostasis in Alzheimer\u2019s disease. J Alzheimers Dis 32:599\u2013608. https:\/\/doi.org\/10.3233\/JAD-2012-120820","journal-title":"J Alzheimers Dis"},{"key":"4589_CR68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M et al (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16:30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2","journal-title":"Nat Rev Neurol"},{"key":"4589_CR69","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","volume":"40","author":"EE Smith","year":"2009","unstructured":"Smith EE, Greenberg SM (2009) \u03b2-Amyloid, blood vessels, and brain function. Stroke 40:2601\u20132606. https:\/\/doi.org\/10.1161\/STROKEAHA.108.536839","journal-title":"Stroke"},{"key":"4589_CR70","doi-asserted-by":"publisher","first-page":"122892","DOI":"10.1016\/j.jns.2024.122892","volume":"457","author":"Y Kobayashi","year":"2024","unstructured":"Kobayashi Y, Hiraoka K, Itabashi R et al (2024) Amyloid accumulation in cases of suspected comorbid cerebral amyloid angiopathy and isolated cortical venous thrombosis. J Neurol Sci 457:122892. https:\/\/doi.org\/10.1016\/j.jns.2024.122892","journal-title":"J Neurol Sci"},{"key":"4589_CR71","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/jth.13340","volume":"14","author":"YC Chung","year":"2016","unstructured":"Chung YC, Kruyer A, Yao Y et al (2016) Hyperhomocysteinemia exacerbates Alzheimer\u2019s disease pathology by way of the \u03b2-amyloid fibrinogen interaction. J Thromb Haemost 14:1442\u20131452. https:\/\/doi.org\/10.1111\/jth.13340","journal-title":"J Thromb Haemost"},{"key":"4589_CR72","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.mp.4001854","volume":"11","author":"IJ Martins","year":"2006","unstructured":"Martins IJ, Hone E, Foster JK et al (2006) Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer\u2019s disease and cardiovascular disease. Mol Psychiatry 11:721\u2013736. https:\/\/doi.org\/10.1038\/sj.mp.4001854","journal-title":"Mol Psychiatry"},{"issue":"10","key":"4589_CR73","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/ijms18102128","volume":"18","author":"C De Luca","year":"2017","unstructured":"De Luca C, Virtuoso A, Maggio N, Papa M (2017) Neuro-coagulopathy: blood coagulation factors in central nervous system diseases. Int J Mol Sci 18(10):2128. https:\/\/doi.org\/10.3390\/ijms18102128","journal-title":"Int J Mol Sci"},{"key":"4589_CR74","first-page":"746","volume":"4","author":"MG Caprio","year":"2016","unstructured":"Caprio MG, Russo C, Giugliano A et al (2016) Vascular disease in patients with multiple sclerosis: a review. J Vasc Med Surg 4:746\u2013753","journal-title":"J Vasc Med Surg"},{"key":"4589_CR75","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1179\/1743132812Y.0000000051","volume":"34","author":"CF Christiansen","year":"2012","unstructured":"Christiansen CF (2012) Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res 34:746\u2013753. https:\/\/doi.org\/10.1179\/1743132812Y.0000000051","journal-title":"Neurol Res"},{"key":"4589_CR76","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.msard.2018.10.008","volume":"27","author":"O Ahmed","year":"2019","unstructured":"Ahmed O, Geraldes R, DeLuca GC, Palace J (2019) Multiple sclerosis and the risk of systemic venous thrombosis: a systematic review. Mult Scler Relat Disord 27:424\u2013430. https:\/\/doi.org\/10.1016\/j.msard.2018.10.008","journal-title":"Mult Scler Relat Disord"},{"key":"4589_CR77","doi-asserted-by":"publisher","first-page":"e2622","DOI":"10.1212\/WNL.0000000000010531","volume":"95","author":"JW Han","year":"2020","unstructured":"Han JW, Maillard P, Harvey D et al (2020) Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory. Neurology 95:e2622\u2013e2634. https:\/\/doi.org\/10.1212\/WNL.0000000000010531","journal-title":"Neurology"},{"key":"4589_CR78","doi-asserted-by":"publisher","first-page":"557384","DOI":"10.3389\/fnagi.2020.557384","volume":"12","author":"C Watanabe","year":"2020","unstructured":"Watanabe C, Imaizumi T, Kawai H et al (2020) Aging of the vascular system and neural diseases. Front Aging Neurosci 12:557384. https:\/\/doi.org\/10.3389\/fnagi.2020.557384","journal-title":"Front Aging Neurosci"},{"key":"4589_CR79","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/jcbfm.2012.25","volume":"32","author":"DB Stanimirovic","year":"2012","unstructured":"Stanimirovic DB, Friedman A (2012) Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab 32:1207\u20131221. https:\/\/doi.org\/10.1038\/jcbfm.2012.25","journal-title":"J Cereb Blood Flow Metab"},{"key":"4589_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","volume":"19","author":"N Mackman","year":"2020","unstructured":"Mackman N, Bergmeier W, Stouffer GA, Weitz JI (2020) Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov 19:333\u2013352. https:\/\/doi.org\/10.1038\/s41573-020-0061-0","journal-title":"Nat Rev Drug Discov"},{"key":"4589_CR81","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1161\/ATVBAHA.119.312003","volume":"39","author":"K Satoh","year":"2019","unstructured":"Satoh K, Satoh T, Yaoita N, Shimokawa H (2019) Recent advances in the understanding of thrombosis. Arterioscler Thromb Vasc Biol 39:e159\u2013e165. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4589_CR82","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00424-016-1839-0","volume":"468","author":"M Siragusa","year":"2016","unstructured":"Siragusa M, Fleming I (2016) The eNOS signalosome and its link to endothelial dysfunction. Pflugers Arch 468:1125\u20131137. https:\/\/doi.org\/10.1007\/s00424-016-1839-0","journal-title":"Pflugers Arch"},{"key":"4589_CR83","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/FJC.0000000000000348","volume":"67","author":"H Shimokawa","year":"2016","unstructured":"Shimokawa H, Godo S (2016) Diverse functions of endothelial NO synthases system: NO and EDH. J Cardiovasc Pharmacol 67:361\u2013366. https:\/\/doi.org\/10.1097\/FJC.0000000000000348","journal-title":"J Cardiovasc Pharmacol"},{"key":"4589_CR84","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.niox.2013.09.004","volume":"35","author":"J Lei","year":"2013","unstructured":"Lei J, Vodovotz Y, Tzeng E, Billiar TR (2013) Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide 35:175\u2013185. https:\/\/doi.org\/10.1016\/j.niox.2013.09.004","journal-title":"Nitric Oxide"},{"key":"4589_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.biopha.2017.10.122","volume":"97","author":"J-Y Chen","year":"2018","unstructured":"Chen J-Y, Ye Z-X, Wang X-F et al (2018) Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed Pharmacother 97:423\u2013428. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.122","journal-title":"Biomed Pharmacother"},{"key":"4589_CR86","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann U, Xia N, Li H (2017) Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res 120:713\u2013735. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309326","journal-title":"Circ Res"},{"key":"4589_CR87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ccc.2019.11.002","volume":"36","author":"T van der Poll","year":"2020","unstructured":"van der Poll T, Parker RI (2020) Platelet activation and endothelial cell dysfunction. Crit Care Clin 36:233\u2013253. https:\/\/doi.org\/10.1016\/j.ccc.2019.11.002","journal-title":"Crit Care Clin"},{"key":"4589_CR88","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1161\/ATVBAHA.118.310367","volume":"38","author":"M Wang","year":"2018","unstructured":"Wang M, Hao H, Leeper NJ, Zhu L (2018) Thrombotic regulation from the endothelial cell perspectives. Arterioscler Thromb Vasc Biol 38:e90\u2013e95. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310367","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"4589_CR89","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","volume":"9","author":"B Nieswandt","year":"2011","unstructured":"Nieswandt B, Pleines I, Bender M (2011) Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 9(Suppl 1):92\u2013104. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04361.x","journal-title":"J Thromb Haemost"},{"key":"4589_CR90","first-page":"197","volume":"3","author":"RJ Kelleher","year":"2013","unstructured":"Kelleher RJ, Soiza RL (2013) Evidence of endothelial dysfunction in the development of Alzheimer\u2019s disease: is Alzheimer\u2019s a vascular disorder? Am J Cardiovasc Dis 3:197\u2013226","journal-title":"Am J Cardiovasc Dis"},{"issue":"6","key":"4589_CR91","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/cells12060962","volume":"12","author":"A Custodia","year":"2023","unstructured":"Custodia A, Aramburu-N\u00fa\u00f1ez M, Rodr\u00edguez-Arrizabalaga M et al (2023) Biomarkers assessing endothelial dysfunction in Alzheimer\u2019s disease. Cells 12(6):962. https:\/\/doi.org\/10.3390\/cells12060962","journal-title":"Cells"},{"key":"4589_CR92","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10571-015-0256-9","volume":"36","author":"K Koizumi","year":"2016","unstructured":"Koizumi K, Wang G, Park L (2016) Endothelial dysfunction and amyloid-\u03b2-induced neurovascular alterations. Cell Mol Neurobiol 36:155\u2013165. https:\/\/doi.org\/10.1007\/s10571-015-0256-9","journal-title":"Cell Mol Neurobiol"},{"key":"4589_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","volume":"354","author":"T M\u00fcller","year":"1999","unstructured":"M\u00fcller T, Werne B, Fowler B, Kuhn W (1999) Nigral endothelial dysfunction, homocysteine, and Parkinson\u2019s disease. Lancet 354:126\u2013127","journal-title":"Lancet"},{"key":"4589_CR94","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00702-015-1452-y","volume":"122","author":"JH Yoon","year":"2015","unstructured":"Yoon JH, Park DK, Yong SW, Hong JM (2015) Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson\u2019s disease. J Neural Transm (Vienna) 122:1685\u20131691. https:\/\/doi.org\/10.1007\/s00702-015-1452-y","journal-title":"J Neural Transm (Vienna)"},{"key":"4589_CR95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bcp.12357","volume":"78","author":"S Cahill-Smith","year":"2014","unstructured":"Cahill-Smith S, Li J-M (2014) Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2. Br J Clin Pharmacol 78:441\u2013453. https:\/\/doi.org\/10.1111\/bcp.12357","journal-title":"Br J Clin Pharmacol"},{"key":"4589_CR96","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.msard.2021.103135","volume":"54","author":"K Senzaki","year":"2021","unstructured":"Senzaki K, Okada Y, Ochi H et al (2021) Vascular endothelial dysfunction associated with severity in multiple sclerosis. Mult Scler Relat Disord 54:103135. https:\/\/doi.org\/10.1016\/j.msard.2021.103135","journal-title":"Mult Scler Relat Disord"},{"key":"4589_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pathophys.2010.04.002","volume":"18","author":"JS Alexander","year":"2011","unstructured":"Alexander JS, Zivadinov R, Maghzi A-H et al (2011) Multiple sclerosis and cerebral endothelial dysfunction: mechanisms. Pathophysiology 18:3\u201312. https:\/\/doi.org\/10.1016\/j.pathophys.2010.04.002","journal-title":"Pathophysiology"},{"key":"4589_CR98","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G et al (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78:160\u2013177. https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"key":"4589_CR99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/mds.10629","volume":"19","author":"J Andrich","year":"2004","unstructured":"Andrich J, Saft C, Arz A et al (2004) Hyperhomocysteinaemia in treated patients with Huntington\u2019s disease homocysteine in HD. Mov Disord 19:226\u2013228. https:\/\/doi.org\/10.1002\/mds.10629","journal-title":"Mov Disord"},{"key":"4589_CR100","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","volume":"309","author":"E Oikonomou","year":"2020","unstructured":"Oikonomou E, Leopoulou M, Theofilis P et al (2020) A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: clinical and therapeutic implications. Atherosclerosis 309:16\u201326. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.07.027","journal-title":"Atherosclerosis"},{"key":"4589_CR101","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jth.14759","volume":"18","author":"MY Najem","year":"2020","unstructured":"Najem MY, Couturaud F, Lemari\u00e9 CA (2020) Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost 18:1009\u20131019. https:\/\/doi.org\/10.1111\/jth.14759","journal-title":"J Thromb Haemost"},{"issue":"Suppl","key":"4589_CR102","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139(Suppl):136\u2013153. https:\/\/doi.org\/10.1111\/jnc.13607","journal-title":"J Neurochem"},{"key":"4589_CR103","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41232-020-00137-4","volume":"40","author":"K Otani","year":"2020","unstructured":"Otani K, Shichita T (2020) Cerebral sterile inflammation in neurodegenerative diseases. Inflamm Regen 40:28. https:\/\/doi.org\/10.1186\/s41232-020-00137-4","journal-title":"Inflamm Regen"},{"key":"4589_CR104","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neulet.2018.07.027","volume":"683","author":"D Li","year":"2018","unstructured":"Li D, Song X, Huang H et al (2018) Association of Parkinson\u2019s disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-\u03b1. Neurosci Lett 683:181\u2013184. https:\/\/doi.org\/10.1016\/j.neulet.2018.07.027","journal-title":"Neurosci Lett"},{"key":"4589_CR105","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","volume":"15","author":"P Italiani","year":"2018","unstructured":"Italiani P, Puxeddu I, Napoletano S et al (2018) Circulating levels of IL-1 family cytokines and receptors in Alzheimer\u2019s disease: new markers of disease progression? J Neuroinflammation 15:342. https:\/\/doi.org\/10.1186\/s12974-018-1376-1","journal-title":"J Neuroinflammation"},{"key":"4589_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.146","volume":"62","author":"A Par\u00e9","year":"2017","unstructured":"Par\u00e9 A, Mailhot B, L\u00e9vesque SA, Lacroix S (2017) Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: breaking the vicious cycle between IL-1\u03b2 and GM-CSF. Brain Behav Immun 62:1\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2016.07.146","journal-title":"Brain Behav Immun"},{"key":"4589_CR107","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fnagi.2018.00439","volume":"10","author":"V Boccardi","year":"2018","unstructured":"Boccardi V, Westman E, Pelini L et al (2018) Differential associations of IL-4 with hippocampal subfields in mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci 10:439. https:\/\/doi.org\/10.3389\/fnagi.2018.00439","journal-title":"Front Aging Neurosci"},{"key":"4589_CR108","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4103\/1673-5374.215250","volume":"12","author":"B Spittau","year":"2017","unstructured":"Spittau B (2017) Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson\u2019s disease. Neural Regen Res 12:1433\u20131434. https:\/\/doi.org\/10.4103\/1673-5374.215250","journal-title":"Neural Regen Res"},{"key":"4589_CR109","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.ymthe.2018.06.024","volume":"26","author":"G Casella","year":"2018","unstructured":"Casella G, Colombo F, Finardi A et al (2018) Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis. Mol Ther 26:2107\u20132118. https:\/\/doi.org\/10.1016\/j.ymthe.2018.06.024","journal-title":"Mol Ther"},{"key":"4589_CR110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"E Lyra","year":"2021","unstructured":"Lyra E, Silva NM, Gon\u00e7alves RA, Pascoal TA et al (2021) Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl Psychiatry 11:251. https:\/\/doi.org\/10.1038\/s41398-021-01349-z","journal-title":"Transl Psychiatry"},{"key":"4589_CR111","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","volume":"370","author":"JR Pereira","year":"2016","unstructured":"Pereira JR, Dos SLV, Santos RMS et al (2016) IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue. J Neurol Sci 370:153\u2013156. https:\/\/doi.org\/10.1016\/j.jns.2016.09.030","journal-title":"J Neurol Sci"},{"key":"4589_CR112","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/nyas.12821","volume":"1351","author":"K Janssens","year":"2015","unstructured":"Janssens K, Slaets H, Hellings N (2015) Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis. Ann N Y Acad Sci 1351:52\u201360. https:\/\/doi.org\/10.1111\/nyas.12821","journal-title":"Ann N Y Acad Sci"},{"key":"4589_CR113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-020-00379-3","volume":"15","author":"MH Wertz","year":"2020","unstructured":"Wertz MH, Pineda SS, Lee H et al (2020) Interleukin-6 deficiency exacerbates Huntington\u2019s disease model phenotypes. Mol Neurodegener 15:29. https:\/\/doi.org\/10.1186\/s13024-020-00379-3","journal-title":"Mol Neurodegener"},{"key":"4589_CR114","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1533317512467680","volume":"28","author":"MA Alsadany","year":"2013","unstructured":"Alsadany MA, Shehata HH, Mohamad MI, Mahfouz RG (2013) Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen 28:54\u201361. https:\/\/doi.org\/10.1177\/1533317512467680","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"4589_CR115","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/01616412.2015.1133026","volume":"38","author":"V Gupta","year":"2016","unstructured":"Gupta V, Garg RK, Khattri S (2016) Levels of IL-8 and TNF-\u03b1 decrease in Parkinson\u2019s disease. Neurol Res 38:98\u2013102. https:\/\/doi.org\/10.1080\/01616412.2015.1133026","journal-title":"Neurol Res"},{"key":"4589_CR116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2017.03.007","volume":"14","author":"Z Matej\u010d\u00edkov\u00e1","year":"2017","unstructured":"Matej\u010d\u00edkov\u00e1 Z, Mare\u0161 J, Sl\u00e1dkov\u00e1 V et al (2017) Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin. Mult Scler Relat Disord 14:12\u201315. https:\/\/doi.org\/10.1016\/j.msard.2017.03.007","journal-title":"Mult Scler Relat Disord"},{"key":"4589_CR117","doi-asserted-by":"publisher","first-page":"117957351770927","DOI":"10.1177\/1179573517709278","volume":"9","author":"R Chang","year":"2017","unstructured":"Chang R, Yee K-L, Sumbria RK (2017) Tumor necrosis factor \u03b1 inhibition for Alzheimer\u2019s disease. J Cent Nerv Syst Dis 9:1179573517709278. https:\/\/doi.org\/10.1177\/1179573517709278","journal-title":"J Cent Nerv Syst Dis"},{"key":"4589_CR118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","volume":"166","author":"E Kouchaki","year":"2018","unstructured":"Kouchaki E, Kakhaki RD, Tamtaji OR et al (2018) Increased serum levels of TNF-\u03b1 and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg 166:76\u201379. https:\/\/doi.org\/10.1016\/j.clineuro.2018.01.022","journal-title":"Clin Neurol Neurosurg"},{"key":"4589_CR119","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00011-019-01286-0","volume":"68","author":"CM Ribeiro","year":"2019","unstructured":"Ribeiro CM, Oliveira SR, Alfieri DF et al (2019) Tumor necrosis factor alpha (TNF-\u03b1) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis. Inflamm Res 68:1049\u20131059. https:\/\/doi.org\/10.1007\/s00011-019-01286-0","journal-title":"Inflamm Res"},{"key":"4589_CR120","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","volume":"23","author":"H-Y Hsiao","year":"2014","unstructured":"Hsiao H-Y, Chiu F-L, Chen C-M et al (2014) Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease. Hum Mol Genet 23:4328\u20134344. https:\/\/doi.org\/10.1093\/hmg\/ddu151","journal-title":"Hum Mol Genet"},{"key":"4589_CR121","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/JCI30284","volume":"116","author":"P Das","year":"2006","unstructured":"Das P, Golde T (2006) Dysfunction of TGF-beta signaling in Alzheimer\u2019s disease. J Clin Invest 116:2855\u20132857. https:\/\/doi.org\/10.1172\/JCI30284","journal-title":"J Clin Invest"},{"key":"4589_CR122","doi-asserted-by":"publisher","first-page":"105805","DOI":"10.1016\/j.nbd.2022.105805","volume":"171","author":"M Karampetsou","year":"2022","unstructured":"Karampetsou M, Vekrellis K, Melachroinou K (2022) The promise of the TGF-\u03b2 superfamily as a therapeutic target for Parkinson\u2019s disease. Neurobiol Dis 171:105805. https:\/\/doi.org\/10.1016\/j.nbd.2022.105805","journal-title":"Neurobiol Dis"},{"key":"4589_CR123","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI40782","volume":"121","author":"M Nosaka","year":"2011","unstructured":"Nosaka M, Ishida Y, Kimura A et al (2011) Absence of IFN-\u03b3 accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice. J Clin Invest 121:2911\u20132920. https:\/\/doi.org\/10.1172\/JCI40782","journal-title":"J Clin Invest"},{"key":"4589_CR124","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/jir.2013.0085","volume":"34","author":"M Belkhelfa","year":"2014","unstructured":"Belkhelfa M, Rafa H, Medjeber O et al (2014) IFN-\u03b3 and TNF-\u03b1 are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res 34:839\u2013847. https:\/\/doi.org\/10.1089\/jir.2013.0085","journal-title":"J Interferon Cytokine Res"},{"key":"4589_CR125","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1172\/JCI31254","volume":"117","author":"JR Lees","year":"2007","unstructured":"Lees JR, Cross AH (2007) A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest 117:297\u2013299. https:\/\/doi.org\/10.1172\/JCI31254","journal-title":"J Clin Invest"},{"key":"4589_CR126","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano G, Ottum PA, Reyes LI et al (2015) Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol 6:492. https:\/\/doi.org\/10.3389\/fimmu.2015.00492","journal-title":"Front Immunol"},{"key":"4589_CR127","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/s0741-5214(99)70014-5","volume":"30","author":"J Humphries","year":"1999","unstructured":"Humphries J, McGuinness CL, Smith A et al (1999) Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 30:894\u2013899. https:\/\/doi.org\/10.1016\/s0741-5214(99)70014-5","journal-title":"J Vasc Surg"},{"key":"4589_CR128","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dadm.2016.05.004","volume":"3","author":"BM Bettcher","year":"2016","unstructured":"Bettcher BM, Fitch R, Wynn MJ et al (2016) MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer\u2019s disease dementia phenotypes. Alzheimers Dement (Amst) 3:91\u201397. https:\/\/doi.org\/10.1016\/j.dadm.2016.05.004","journal-title":"Alzheimers Dement (Amst)"},{"key":"4589_CR129","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","volume":"8","author":"W-J Lee","year":"2018","unstructured":"Lee W-J, Liao Y-C, Wang Y-F et al (2018) Plasma MCP-1 and cognitive decline in patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study. Sci Rep 8:1280. https:\/\/doi.org\/10.1038\/s41598-018-19807-y","journal-title":"Sci Rep"},{"key":"4589_CR130","doi-asserted-by":"publisher","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","volume":"3","author":"E Wild","year":"2011","unstructured":"Wild E, Magnusson A, Lahiri N et al (2011) Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLoS Curr 3:RRN1231. https:\/\/doi.org\/10.1371\/currents.RRN1231","journal-title":"PLoS Curr"},{"key":"4589_CR131","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1038\/srep13281","volume":"5","author":"M Slevin","year":"2015","unstructured":"Slevin M, Matou S, Zeinolabediny Y et al (2015) Monomeric C-reactive protein\u2013a key molecule driving development of Alzheimer\u2019s disease associated with brain ischaemia? Sci Rep 5:13281. https:\/\/doi.org\/10.1038\/srep13281","journal-title":"Sci Rep"},{"key":"4589_CR132","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10072-010-0335-0","volume":"32","author":"I-U Song","year":"2011","unstructured":"Song I-U, Chung S-W, Kim J-S, Lee K-S (2011) Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson\u2019s disease. Neurol Sci 32:31\u201334. https:\/\/doi.org\/10.1007\/s10072-010-0335-0","journal-title":"Neurol Sci"},{"key":"4589_CR133","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41531-022-00302-1","volume":"8","author":"P Lyra","year":"2022","unstructured":"Lyra P, Botelho J, Machado V et al (2022) Self-reported periodontitis and C-reactive protein in Parkinson\u2019s disease: a cross-sectional study of two American cohorts. NPJ Parkinsons Dis 8:40. https:\/\/doi.org\/10.1038\/s41531-022-00302-1","journal-title":"NPJ Parkinsons Dis"},{"key":"4589_CR134","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","volume":"108","author":"KA Tanaka","year":"2009","unstructured":"Tanaka KA, Key NS, Levy JH (2009) Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 108:1433\u20131446. https:\/\/doi.org\/10.1213\/ane.0b013e31819bcc9c","journal-title":"Anesth Analg"},{"key":"4589_CR135","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1161\/ATVBAHA.120.312674","volume":"40","author":"X Li","year":"2020","unstructured":"Li X, Sim MMS, Wood JP (2020) Recent insights into the regulation of coagulation and thrombosis. Arterioscler Thromb Vasc Biol 40:e119\u2013e125. https:\/\/doi.org\/10.1161\/ATVBAHA.120.312674","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 5","key":"4589_CR136","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2516.2008.01848.x","volume":"14","author":"AJ Reininger","year":"2008","unstructured":"Reininger AJ (2008) Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 14(Suppl 5):11\u201326. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01848.x","journal-title":"Haemophilia"},{"key":"4589_CR137","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1440-1797.2009.01128.x","volume":"14","author":"RLC Adams","year":"2009","unstructured":"Adams RLC, Bird RJ (2009) Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) 14:462\u2013470. https:\/\/doi.org\/10.1111\/j.1440-1797.2009.01128.x","journal-title":"Nephrology (Carlton)"},{"key":"4589_CR138","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2024.01.024","volume":"235","author":"LB Harrington","year":"2024","unstructured":"Harrington LB, Ehlert AN, Thacker EL et al (2024) Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: the Cardiovascular Health Study. Thromb Res 235:148\u2013154. https:\/\/doi.org\/10.1016\/j.thromres.2024.01.024","journal-title":"Thromb Res"},{"key":"4589_CR139","doi-asserted-by":"publisher","first-page":"15682","DOI":"10.18632\/aging.103776","volume":"12","author":"T Wang","year":"2020","unstructured":"Wang T, Yuan F, Chen Z et al (2020) Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson\u2019s disease patients with type 2 diabetes mellitus. Aging 12:15682\u201315704. https:\/\/doi.org\/10.18632\/aging.103776","journal-title":"Aging"},{"key":"4589_CR140","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neubiorev.2020.02.022","volume":"112","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Liang Y, Zhang X et al (2020) Fibrinogen and risk of dementia: a systematic review and meta-analysis. Neurosci Biobehav Rev 112:353\u2013360. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.02.022","journal-title":"Neurosci Biobehav Rev"},{"key":"4589_CR141","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","volume":"66","author":"M Cortes-Canteli","year":"2010","unstructured":"Cortes-Canteli M, Paul J, Norris EH et al (2010) Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer\u2019s disease. Neuron 66:695\u2013709. https:\/\/doi.org\/10.1016\/j.neuron.2010.05.014","journal-title":"Neuron"},{"key":"4589_CR142","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.2174\/092986707782360015","volume":"14","author":"RA Adams","year":"2007","unstructured":"Adams RA, Schachtrup C, Davalos D et al (2007) Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr Med Chem 14:2925\u20132936. https:\/\/doi.org\/10.2174\/092986707782360015","journal-title":"Curr Med Chem"},{"key":"4589_CR143","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s11064-023-03981-1","volume":"48","author":"M Alruwaili","year":"2023","unstructured":"Alruwaili M, Al-Kuraishy HM, Alexiou A et al (2023) Pathogenic role of fibrinogen in the neuropathology of multiple sclerosis: a tale of sorrows and fears. Neurochem Res 48:3255\u20133269. https:\/\/doi.org\/10.1007\/s11064-023-03981-1","journal-title":"Neurochem Res"},{"key":"4589_CR144","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","volume":"45","author":"S Franciosi","year":"2012","unstructured":"Franciosi S, Ryu JK, Shim Y et al (2012) Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Neurobiol Dis 45:438\u2013449. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.003","journal-title":"Neurobiol Dis"},{"key":"4589_CR145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.jnen.0000196133.74087.cb","volume":"65","author":"T Arai","year":"2006","unstructured":"Arai T, Miklossy J, Klegeris A et al (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol 65:19\u201325. https:\/\/doi.org\/10.1097\/01.jnen.0000196133.74087.cb","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"4589_CR146","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijms17010084","volume":"17","author":"H Krenzlin","year":"2016","unstructured":"Krenzlin H, Lorenz V, Danckwardt S et al (2016) The importance of thrombin in cerebral injury and disease. Int J Mol Sci 17(1):84. https:\/\/doi.org\/10.3390\/ijms17010084","journal-title":"Int J Mol Sci"},{"key":"4589_CR147","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1038\/srep14764","volume":"5","author":"W-H Shin","year":"2015","unstructured":"Shin W-H, Jeon M-T, Leem E et al (2015) Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson\u2019s disease. Sci Rep 5:14764. https:\/\/doi.org\/10.1038\/srep14764","journal-title":"Sci Rep"},{"key":"4589_CR148","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ana.24807","volume":"80","author":"K G\u00f6bel","year":"2016","unstructured":"G\u00f6bel K, Kraft P, Pankratz S et al (2016) Prothrombin and factor X are elevated in multiple sclerosis patients. Ann Neurol 80:946\u2013951. https:\/\/doi.org\/10.1002\/ana.24807","journal-title":"Ann Neurol"},{"key":"4589_CR149","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11011-020-00652-w","volume":"36","author":"KR Jordan","year":"2021","unstructured":"Jordan KR, Parra-Izquierdo I, Gruber A et al (2021) Thrombin generation and activity in multiple sclerosis. Metab Brain Dis 36:407\u2013420. https:\/\/doi.org\/10.1007\/s11011-020-00652-w","journal-title":"Metab Brain Dis"},{"key":"4589_CR150","doi-asserted-by":"publisher","first-page":"e15809","DOI":"10.1371\/journal.pone.0015809","volume":"6","author":"Y-C Huang","year":"2011","unstructured":"Huang Y-C, Wu Y-R, Tseng M-Y et al (2011) Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington\u2019s disease. PLoS ONE 6:e15809. https:\/\/doi.org\/10.1371\/journal.pone.0015809","journal-title":"PLoS ONE"},{"key":"4589_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-160196","volume":"5","author":"LM Byrne","year":"2016","unstructured":"Byrne LM, Wild EJ (2016) Cerebrospinal fluid biomarkers for Huntington\u2019s disease. J Huntingtons Dis 5:1\u201313. https:\/\/doi.org\/10.3233\/JHD-160196","journal-title":"J Huntingtons Dis"},{"key":"4589_CR152","first-page":"491","volume":"139","author":"RD McComb","year":"1991","unstructured":"McComb RD, Miller KA, Carson SD (1991) Tissue factor antigen in senile plaques of Alzheimer\u2019s disease. Am J Pathol 139:491\u2013494","journal-title":"Am J Pathol"},{"key":"4589_CR153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0022-510x(03)00101-1","volume":"212","author":"Y Sato","year":"2003","unstructured":"Sato Y, Kaji M, Metoki N et al (2003) Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents. J Neurol Sci 212:55\u201358. https:\/\/doi.org\/10.1016\/s0022-510x(03)00101-1","journal-title":"J Neurol Sci"},{"key":"4589_CR154","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","volume":"1865","author":"BC-K Tong","year":"2018","unstructured":"Tong BC-K, Wu AJ, Li M, Cheung K-H (2018) Calcium signaling in Alzheimer\u2019s disease & therapies. Biochim Biophys Acta Mol Cell Res 1865:1745\u20131760. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.07.018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"9","key":"4589_CR155","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/ijms22094914","volume":"22","author":"R Cascella","year":"2021","unstructured":"Cascella R, Cecchi C (2021) Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 22(9):4914. https:\/\/doi.org\/10.3390\/ijms22094914","journal-title":"Int J Mol Sci"},{"key":"4589_CR156","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","volume":"357","author":"T Cal\u00ec","year":"2014","unstructured":"Cal\u00ec T, Ottolini D, Brini M (2014) Calcium signaling in Parkinson\u2019s disease. Cell Tissue Res 357:439\u2013454. https:\/\/doi.org\/10.1007\/s00441-014-1866-0","journal-title":"Cell Tissue Res"},{"issue":"9","key":"4589_CR157","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/cells9092045","volume":"9","author":"E Zampese","year":"2020","unstructured":"Zampese E, Surmeier DJ (2020) Calcium, bioenergetics, and Parkinson\u2019s disease. Cells 9(9):2045. https:\/\/doi.org\/10.3390\/cells9092045","journal-title":"Cells"},{"key":"4589_CR158","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1042\/BST0350923","volume":"35","author":"MP Kurnellas","year":"2007","unstructured":"Kurnellas MP, Donahue KC, Elkabes S (2007) Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers. Biochem Soc Trans 35:923\u2013926. https:\/\/doi.org\/10.1042\/BST0350923","journal-title":"Biochem Soc Trans"},{"key":"4589_CR159","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1055\/s-0043-109031","volume":"1","author":"E Frohman","year":"2017","unstructured":"Frohman E, Racke M, Raine C et al (2017) Calcium homeostasis in multiple sclerosis. Neurol Int Open 1:E127\u2013E135","journal-title":"Neurol Int Open"},{"key":"4589_CR160","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","volume":"45","author":"I Bezprozvanny","year":"2007","unstructured":"Bezprozvanny I (2007) Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington\u2019s disease. Subcell Biochem 45:323\u2013335. https:\/\/doi.org\/10.1007\/978-1-4020-6191-2_11","journal-title":"Subcell Biochem"},{"key":"4589_CR161","doi-asserted-by":"publisher","first-page":"611735","DOI":"10.3389\/fcell.2020.611735","volume":"8","author":"M Czeredys","year":"2020","unstructured":"Czeredys M (2020) Dysregulation of neuronal calcium signaling via store-operated channels in Huntington\u2019s disease. Front Cell Dev Biol 8:611735. https:\/\/doi.org\/10.3389\/fcell.2020.611735","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"4589_CR162","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archneur.1959.03840030073008","volume":"1","author":"SD Albright","year":"1959","unstructured":"Albright SD, Kupfer HG, Kinne DR (1959) A study of coagulation factors in blood and spinal fluid in multiple sclerosis. AMA Arch Neurol 1(3):315\u2013326. https:\/\/doi.org\/10.1001\/archneur.1959.03840030073008","journal-title":"AMA Arch Neurol"},{"key":"4589_CR163","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1742-1241.2004.00143.x","volume":"59","author":"A Gupta","year":"2005","unstructured":"Gupta A, Watkins A, Thomas P et al (2005) Coagulation and inflammatory markers in Alzheimer\u2019s and vascular dementia. Int J Clin Pract 59:52\u201357. https:\/\/doi.org\/10.1111\/j.1742-1241.2004.00143.x","journal-title":"Int J Clin Pract"},{"key":"4589_CR164","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41366-021-00977-1","volume":"46","author":"S Khan","year":"2022","unstructured":"Khan S, Pati S, Singh S et al (2022) Targeting hypercoagulation to alleviate Alzheimer\u2019s disease progression in metabolic syndrome. Int J Obes (Lond) 46:245\u2013254. https:\/\/doi.org\/10.1038\/s41366-021-00977-1","journal-title":"Int J Obes (Lond)"},{"key":"4589_CR165","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sj.bmt.1704550","volume":"34","author":"P Kaloyannidis","year":"2004","unstructured":"Kaloyannidis P, Sakellari I, Fassas A et al (2004) Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a. Bone Marrow Transplant 34:187\u2013188","journal-title":"Bone Marrow Transplant"},{"key":"4589_CR166","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fneur.2014.00119","volume":"5","author":"T Koudriavtseva","year":"2014","unstructured":"Koudriavtseva T (2014) Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Front Neurol 5:119. https:\/\/doi.org\/10.3389\/fneur.2014.00119","journal-title":"Front Neurol"},{"key":"4589_CR167","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fneur.2019.00409","volume":"10","author":"N Ziliotto","year":"2019","unstructured":"Ziliotto N, Bernardi F, Jakimovski D, Zivadinov R (2019) Coagulation pathways in neurological diseases: multiple sclerosis. Front Neurol 10:409. https:\/\/doi.org\/10.3389\/fneur.2019.00409","journal-title":"Front Neurol"},{"key":"4589_CR168","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/s0196-9781(02)00063-3","volume":"23","author":"G Evin","year":"2002","unstructured":"Evin G, Weidemann A (2002) Biogenesis and metabolism of Alzheimer\u2019s disease Abeta amyloid peptides. Peptides (NY) 23:1285\u20131297. https:\/\/doi.org\/10.1016\/s0196-9781(02)00063-3","journal-title":"Peptides (NY)"},{"key":"4589_CR169","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pmbts.2019.06.003","volume":"168","author":"G \u0160imi\u0107","year":"2019","unstructured":"\u0160imi\u0107 G, \u0160pani\u0107 E, Langer Horvat L, Hof PR (2019) Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 168:99\u2013145. https:\/\/doi.org\/10.1016\/bs.pmbts.2019.06.003","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4589_CR170","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOH.0000000000000368","volume":"24","author":"HJ Ahn","year":"2017","unstructured":"Ahn HJ, Chen Z-L, Zamolodchikov D et al (2017) Interactions of \u03b2-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer\u2019s disease. Curr Opin Hematol 24:427\u2013431. https:\/\/doi.org\/10.1097\/MOH.0000000000000368","journal-title":"Curr Opin Hematol"},{"key":"4589_CR171","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WAD.0000000000000420","volume":"35","author":"KA Garc\u00eda-Mej\u00eda","year":"2021","unstructured":"Garc\u00eda-Mej\u00eda KA, Custodio-Chabl\u00e9 SJ, V\u00e1zquez-Franco JE et al (2021) \u03b2-Amyloid orchestrates factor XII and platelet activation leading to endothelial dysfunction and abnormal fibrinolysis in Alzheimer disease. Alzheimer Dis Assoc Disord 35:91\u201397. https:\/\/doi.org\/10.1097\/WAD.0000000000000420","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4589_CR172","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fneur.2019.00095","volume":"10","author":"S La Starza","year":"2019","unstructured":"La Starza S, Ferraldeschi M, Buscarinu MC et al (2019) Genome-wide multiple sclerosis association data and coagulation. Front Neurol 10:95. https:\/\/doi.org\/10.3389\/fneur.2019.00095","journal-title":"Front Neurol"},{"key":"4589_CR173","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1179\/016164106X110454","volume":"28","author":"L Gerardino","year":"2006","unstructured":"Gerardino L, Papaleo P, Flex A et al (2006) Coagulation factor XIII Val34Leu gene polymorphism and Alzheimer\u2019s disease. Neurol Res 28:807\u2013809. https:\/\/doi.org\/10.1179\/016164106X110454","journal-title":"Neurol Res"},{"key":"4589_CR174","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1021\/acs.biochem.0c00450","volume":"59","author":"WS Hur","year":"2020","unstructured":"Hur WS, Juang LJ, Mazinani N et al (2020) Post-translational modifications of platelet-derived amyloid precursor protein by coagulation factor XIII-A. Biochemistry 59:4449\u20134455. https:\/\/doi.org\/10.1021\/acs.biochem.0c00450","journal-title":"Biochemistry"},{"issue":"8","key":"4589_CR175","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/biology10080716","volume":"10","author":"A Sharma","year":"2021","unstructured":"Sharma A, M\u00fcller J, Schuetze K et al (2021) Comprehensive profiling of blood coagulation and fibrinolysis marker reveals elevated plasmin-antiplasmin complexes in Parkinson\u2019s disease. Biology (Basel) 10(8):716. https:\/\/doi.org\/10.3390\/biology10080716","journal-title":"Biology (Basel)"},{"key":"4589_CR176","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden PEJ, Heemskerk JWM (2019) Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol 16:166\u2013179","journal-title":"Nat Rev Cardiol"},{"key":"4589_CR177","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1152\/physiol.00020.2016","volume":"32","author":"B Estevez","year":"2017","unstructured":"Estevez B, Du X (2017) New concepts and mechanisms of platelet activation signaling. Physiology (Bethesda) 32:162\u2013177. https:\/\/doi.org\/10.1152\/physiol.00020.2016","journal-title":"Physiology (Bethesda)"},{"key":"4589_CR178","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","volume":"36","author":"M Holinstat","year":"2017","unstructured":"Holinstat M (2017) Normal platelet function. Cancer Metastasis Rev 36:195\u2013198. https:\/\/doi.org\/10.1007\/s10555-017-9677-x","journal-title":"Cancer Metastasis Rev"},{"key":"4589_CR179","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/rth2.12107","volume":"2","author":"F Swieringa","year":"2018","unstructured":"Swieringa F, Spronk HMH, Heemskerk JWM, van der Meijden PEJ (2018) Integrating platelet and coagulation activation in fibrin clot formation. Res Pract Thromb Haemost 2:450\u2013460. https:\/\/doi.org\/10.1002\/rth2.12107","journal-title":"Res Pract Thromb Haemost"},{"key":"4589_CR180","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-023-03003-5","volume":"21","author":"M Shi","year":"2024","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2024) Peripheral blood amyloid-\u03b2 involved in the pathogenesis of Alzheimer\u2019s disease via impacting on peripheral innate immune cells. J Neuroinflammation 21:5. https:\/\/doi.org\/10.1186\/s12974-023-03003-5","journal-title":"J Neuroinflammation"},{"key":"4589_CR181","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood.2022015970","volume":"140","author":"T Burnouf","year":"2022","unstructured":"Burnouf T, Walker TL (2022) The multifaceted role of platelets in mediating brain function. Blood 140:815\u2013827. https:\/\/doi.org\/10.1182\/blood.2022015970","journal-title":"Blood"},{"key":"4589_CR182","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12035-021-02587-4","volume":"59","author":"SK Beura","year":"2022","unstructured":"Beura SK, Panigrahi AR, Yadav P et al (2022) Role of neurons and glia cells in wound healing as a novel perspective considering platelet as a conventional player. Mol Neurobiol 59:137\u2013160. https:\/\/doi.org\/10.1007\/s12035-021-02587-4","journal-title":"Mol Neurobiol"},{"key":"4589_CR183","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1002\/alz.13841","volume":"20","author":"J Fu","year":"2024","unstructured":"Fu J, Lai X, Zhang C et al (2024) Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer\u2019s disease. Alzheimer\u2019s Demen 20:4366\u20134372. https:\/\/doi.org\/10.1002\/alz.13841","journal-title":"Alzheimer\u2019s Demen"},{"key":"4589_CR184","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.cellsig.2016.08.017","volume":"28","author":"I Canobbio","year":"2016","unstructured":"Canobbio I, Visconte C, Oliviero B et al (2016) Increased platelet adhesion and thrombus formation in a mouse model of Alzheimer\u2019s disease. Cell Signal 28:1863\u20131871. https:\/\/doi.org\/10.1016\/j.cellsig.2016.08.017","journal-title":"Cell Signal"},{"key":"4589_CR185","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2119\/molmed.2016.00003","volume":"22","author":"V Sonkar","year":"2016","unstructured":"Sonkar V, Kulkarni PP, Chaurasia SN et al (2016) Plasma fibrinogen is a natural deterrent to amyloid beta-induced platelet activation. Mol Med 22:224\u2013232. https:\/\/doi.org\/10.2119\/molmed.2016.00003","journal-title":"Mol Med"},{"key":"4589_CR186","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.thromres.2010.01.009","volume":"125","author":"A Reheman","year":"2010","unstructured":"Reheman A, Tasneem S, Ni H, Hayward CPM (2010) Mice with deleted multimerin 1 and alpha-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1. Thromb Res 125:e177\u2013e183. https:\/\/doi.org\/10.1016\/j.thromres.2010.01.009","journal-title":"Thromb Res"},{"key":"4589_CR187","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bcmd.2018.09.001","volume":"73","author":"H Tashkandi","year":"2018","unstructured":"Tashkandi H, Shameli A, Harding CV, Maitta RW (2018) Ultrastructural changes in peripheral blood leukocytes in \u03b1-synuclein knockout mice. Blood Cells Mol Dis 73:33\u201337. https:\/\/doi.org\/10.1016\/j.bcmd.2018.09.001","journal-title":"Blood Cells Mol Dis"},{"key":"4589_CR188","first-page":"462","volume":"28","author":"M Nathanson","year":"1952","unstructured":"Nathanson M, Savitsky JP (1952) Platelet adhesive index studies in multiple sclerosis and other neurologic disorders. Bull N Y Acad Med 28:462\u2013468","journal-title":"Bull N Y Acad Med"},{"key":"4589_CR189","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/BF00243772","volume":"191","author":"P Millac","year":"1967","unstructured":"Millac P (1967) Platelet stickiness in multiple sclerosis. Dtsch Z Nervenheilkd 191:74\u201379. https:\/\/doi.org\/10.1007\/BF00243772","journal-title":"Dtsch Z Nervenheilkd"},{"key":"4589_CR190","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1096\/fj.13-243691","volume":"28","author":"VK Sonkar","year":"2014","unstructured":"Sonkar VK, Kulkarni PP, Dash D (2014) Amyloid \u03b2 peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization. FASEB J 28:1819\u20131829. https:\/\/doi.org\/10.1096\/fj.13-243691","journal-title":"FASEB J"},{"key":"4589_CR191","doi-asserted-by":"publisher","first-page":"1050476","DOI":"10.1155\/2019\/1050476","volume":"2019","author":"AA Abubaker","year":"2019","unstructured":"Abubaker AA, Vara D, Visconte C et al (2019) Amyloid peptide \u03b21-42 induces integrin \u03b1IIb\u03b23 activation, platelet adhesion, and thrombus formation in a NADPH oxidase-dependent manner. Oxid Med Cell Longev 2019:1050476. https:\/\/doi.org\/10.1155\/2019\/1050476","journal-title":"Oxid Med Cell Longev"},{"key":"4589_CR192","doi-asserted-by":"publisher","first-page":"103952","DOI":"10.1016\/j.mcn.2024.103952","volume":"130","author":"L Donner","year":"2024","unstructured":"Donner L, Kr\u00fcger I, Pfeiler S et al (2024) Reduced platelet activation and thrombus formation in male transgenic model mice of Alzheimer\u2019s disease suggests early sex-specific differences in platelet pathophysiology. Mol Cell Neurosci 130:103952. https:\/\/doi.org\/10.1016\/j.mcn.2024.103952","journal-title":"Mol Cell Neurosci"},{"key":"4589_CR193","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-5-27","volume":"5","author":"WA Sheremata","year":"2008","unstructured":"Sheremata WA, Jy W, Horstman LL et al (2008) Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 5:27. https:\/\/doi.org\/10.1186\/1742-2094-5-27","journal-title":"J Neuroinflammation"},{"key":"4589_CR194","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-017-2955-7","volume":"430","author":"A Morel","year":"2017","unstructured":"Morel A, Rywaniak J, Bijak M et al (2017) Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients. Mol Cell Biochem 430:69\u201380. https:\/\/doi.org\/10.1007\/s11010-017-2955-7","journal-title":"Mol Cell Biochem"},{"key":"4589_CR195","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2019.00210","volume":"11","author":"B Adams","year":"2019","unstructured":"Adams B, Nunes JM, Page MJ et al (2019) Parkinson\u2019s disease: a systemic inflammatory disease accompanied by bacterial inflammagens. Front Aging Neurosci 11:210. https:\/\/doi.org\/10.3389\/fnagi.2019.00210","journal-title":"Front Aging Neurosci"},{"key":"4589_CR196","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1182\/blood.V100.7.2506","volume":"100","author":"SM Park","year":"2002","unstructured":"Park SM, Jung HY, Kim HO et al (2002) Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets. Blood 100:2506\u20132514. https:\/\/doi.org\/10.1182\/blood.V100.7.2506","journal-title":"Blood"},{"key":"4589_CR197","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1600-0404.1982.tb06872.x","volume":"66","author":"IS Neu","year":"1982","unstructured":"Neu IS, Prosiegel M, Pfaffenrath V (1982) Platelet aggregation and multiple sclerosis. Acta Neurol Scand 66:497\u2013504. https:\/\/doi.org\/10.1111\/j.1600-0404.1982.tb06872.x","journal-title":"Acta Neurol Scand"},{"key":"4589_CR198","doi-asserted-by":"publisher","unstructured":"Pontarollo G, Acquasaliente L, Radu CM et al (2021) Human \u03b1-synuclein inhibits platelets aggregation in vitro by interfering with the \u03b1-thrombin\/protease-activated receptor 1 functional axis. BioRxiv 2003\u20132021. https:\/\/doi.org\/10.1101\/2021.03.28.437436","DOI":"10.1101\/2021.03.28.437436"},{"key":"4589_CR199","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/BJ20140307","volume":"462","author":"I Canobbio","year":"2014","unstructured":"Canobbio I, Guidetti GF, Oliviero B et al (2014) Amyloid \u03b2-peptide-dependent activation of human platelets: essential role for Ca2+ and ADP in aggregation and thrombus formation. Biochem J 462:513\u2013523. https:\/\/doi.org\/10.1042\/BJ20140307","journal-title":"Biochem J"},{"key":"4589_CR200","doi-asserted-by":"publisher","first-page":"269","DOI":"10.21307\/ane-2017-026","volume":"76","author":"B Wachowicz","year":"2016","unstructured":"Wachowicz B, Morel A, Miller E, Saluk J (2016) The physiology of blood platelets and changes of their biological activities in multiple sclerosis. Acta Neurobiol Exp (Wars) 76:269\u2013281. https:\/\/doi.org\/10.21307\/ane-2017-026","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"4589_CR201","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/00207454.2012.751534","volume":"123","author":"M Behari","year":"2013","unstructured":"Behari M, Shrivastava M (2013) Role of platelets in neurodegenerative diseases: a universal pathophysiology. Int J Neurosci 123:287\u2013299. https:\/\/doi.org\/10.3109\/00207454.2012.751534","journal-title":"Int J Neurosci"},{"key":"4589_CR202","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jnnp-2018-318854","volume":"90","author":"HL Denis","year":"2019","unstructured":"Denis HL, Lamontagne-Proulx J, St-Amour I et al (2019) Platelet abnormalities in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 90:272\u2013283. https:\/\/doi.org\/10.1136\/jnnp-2018-318854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4589_CR203","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fncel.2015.00065","volume":"9","author":"I Canobbio","year":"2015","unstructured":"Canobbio I, Abubaker AA, Visconte C et al (2015) Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer\u2019s disease. Front Cell Neurosci 9:65. https:\/\/doi.org\/10.3389\/fncel.2015.00065","journal-title":"Front Cell Neurosci"},{"key":"4589_CR204","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4933-9-20","volume":"9","author":"S Catricala","year":"2012","unstructured":"Catricala S, Torti M, Ricevuti G (2012) Alzheimer disease and platelets: how\u2019s that relevant. Immun Ageing 9:20. https:\/\/doi.org\/10.1186\/1742-4933-9-20","journal-title":"Immun Ageing"},{"key":"4589_CR205","doi-asserted-by":"publisher","first-page":"e90523","DOI":"10.1371\/journal.pone.0090523","volume":"9","author":"NS Gowert","year":"2014","unstructured":"Gowert NS, Donner L, Chatterjee M et al (2014) Blood platelets in the progression of Alzheimer\u2019s disease. PLoS ONE 9:e90523. https:\/\/doi.org\/10.1371\/journal.pone.0090523","journal-title":"PLoS ONE"},{"key":"4589_CR206","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1006\/bbrc.1997.6978","volume":"237","author":"M Hashimoto","year":"1997","unstructured":"Hashimoto M, Yoshimoto M, Sisk A et al (1997) NACP, a synaptic protein involved in Alzheimer\u2019s disease, is differentially regulated during megakaryocyte differentiation. Biochem Biophys Res Commun 237:611\u2013616. https:\/\/doi.org\/10.1006\/bbrc.1997.6978","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"4589_CR207","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.3390\/ijms22179633","volume":"22","author":"L Donner","year":"2021","unstructured":"Donner L, Feige T, Freiburg C et al (2021) Impact of amyloid-\u03b2 on platelet mitochondrial function and platelet-mediated amyloid aggregation in Alzheimer\u2019s disease. Int J Mol Sci 22(17):9633. https:\/\/doi.org\/10.3390\/ijms22179633","journal-title":"Int J Mol Sci"},{"key":"4589_CR208","doi-asserted-by":"publisher","first-page":"105512","DOI":"10.1016\/j.nbd.2021.105512","volume":"159","author":"P Ferrer-Ravent\u00f3s","year":"2021","unstructured":"Ferrer-Ravent\u00f3s P, Beyer K (2021) Alternative platelet activation pathways and their role in neurodegenerative diseases. Neurobiol Dis 159:105512. https:\/\/doi.org\/10.1016\/j.nbd.2021.105512","journal-title":"Neurobiol Dis"},{"key":"4589_CR209","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fimmu.2020.00747","volume":"11","author":"O Leiter","year":"2020","unstructured":"Leiter O, Walker TL (2020) Platelets in neurodegenerative conditions-friend or foe? Front Immunol 11:747. https:\/\/doi.org\/10.3389\/fimmu.2020.00747","journal-title":"Front Immunol"},{"key":"4589_CR210","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/2051-5960-2-65","volume":"2","author":"M Veitinger","year":"2014","unstructured":"Veitinger M, Varga B, Guterres SB, Zellner M (2014) Platelets, a reliable source for peripheral Alzheimer\u2019s disease biomarkers? Acta Neuropathol Commun 2:65. https:\/\/doi.org\/10.1186\/2051-5960-2-65","journal-title":"Acta Neuropathol Commun"},{"key":"4589_CR211","doi-asserted-by":"publisher","first-page":"571083","DOI":"10.3389\/fimmu.2020.571083","volume":"11","author":"M Inyushin","year":"2020","unstructured":"Inyushin M, Zayas-Santiago A, Rojas L, Kucheryavykh L (2020) On the role of platelet-generated amyloid beta peptides in certain amyloidosis health complications. Front Immunol 11:571083. https:\/\/doi.org\/10.3389\/fimmu.2020.571083","journal-title":"Front Immunol"},{"key":"4589_CR212","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/trf.12874","volume":"55","author":"A Pienimaeki-Roemer","year":"2015","unstructured":"Pienimaeki-Roemer A, Kuhlmann K, B\u00f6ttcher A et al (2015) Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets. Transfusion (Paris) 55:507\u2013521. https:\/\/doi.org\/10.1111\/trf.12874","journal-title":"Transfusion (Paris)"},{"key":"4589_CR213","doi-asserted-by":"publisher","first-page":"e02590","DOI":"10.1016\/j.heliyon.2019.e02590","volume":"5","author":"Y Pei","year":"2019","unstructured":"Pei Y, Maitta RW (2019) Alpha synuclein in hematopoiesis and immunity. Heliyon 5:e02590. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02590","journal-title":"Heliyon"},{"key":"4589_CR214","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/jnnp.70.2.229","volume":"70","author":"G Zhou","year":"2001","unstructured":"Zhou G, Miura Y, Shoji H et al (2001) Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 70:229\u2013231. https:\/\/doi.org\/10.1136\/jnnp.70.2.229","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4589_CR215","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/jcm13051245","volume":"13","author":"PA Bilodeau","year":"2024","unstructured":"Bilodeau PA, Dickson JR, Kozberg MG (2024) The impact of anti-amyloid immunotherapies on stroke care. J Clin Med 13:1245. https:\/\/doi.org\/10.3390\/jcm13051245","journal-title":"J Clin Med"},{"key":"4589_CR216","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-023-00637-0","volume":"18","author":"VK Ramanan","year":"2023","unstructured":"Ramanan VK, Day GS (2023) Anti-amyloid therapies for Alzheimer disease: finally, good news for patients. Mol Neurodegener 18:42. https:\/\/doi.org\/10.1186\/s13024-023-00637-0","journal-title":"Mol Neurodegener"},{"key":"4589_CR217","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/agm2.12243","volume":"6","author":"S Mathur","year":"2023","unstructured":"Mathur S, Gawas C, Ahmad IZ et al (2023) Neurodegenerative disorders: assessing the impact of natural vs drug-induced treatment options. AGING MEDICINE 6:82\u201397. https:\/\/doi.org\/10.1002\/agm2.12243","journal-title":"AGING MEDICINE"},{"key":"4589_CR218","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1124\/mol.114.096446","volume":"88","author":"B Chen","year":"2015","unstructured":"Chen B, Soto AG, Coronel LJ et al (2015) Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro. Mol Pharmacol 88:95\u2013105. https:\/\/doi.org\/10.1124\/mol.114.096446","journal-title":"Mol Pharmacol"},{"key":"4589_CR219","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11239-017-1512-2","volume":"44","author":"PJ Vinholt","year":"2017","unstructured":"Vinholt PJ, Nielsen C, S\u00f6derstr\u00f6m AC et al (2017) Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner. J Thromb Thrombolysis 44:216\u2013222. https:\/\/doi.org\/10.1007\/s11239-017-1512-2","journal-title":"J Thromb Thrombolysis"},{"key":"4589_CR220","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.bbrep.2020.100862","volume":"24","author":"J Iannucci","year":"2020","unstructured":"Iannucci J, Johnson SL, Majchrzak M et al (2020) Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer\u2019s disease mouse model. Biochem Biophys Rep 24:100862. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100862","journal-title":"Biochem Biophys Rep"},{"key":"4589_CR221","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.jacc.2019.07.081","volume":"74","author":"M Cortes-Canteli","year":"2019","unstructured":"Cortes-Canteli M, Kruyer A, Fernandez-Nueda I et al (2019) Long-term dabigatran treatment delays Alzheimer\u2019s disease pathogenesis in the TgCRND8 mouse model. J Am Coll Cardiol 74:1910\u20131923. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.081","journal-title":"J Am Coll Cardiol"},{"key":"4589_CR222","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1007\/s12035-017-0636-x","volume":"55","author":"EA Kandil","year":"2018","unstructured":"Kandil EA, Sayed RH, Ahmed LA et al (2018) Modulatory role of Nurr1 activation and thrombin inhibition in the neuroprotective effects of dabigatran etexilate in rotenone-induced Parkinson\u2019s disease in rats. Mol Neurobiol 55:4078\u20134089. https:\/\/doi.org\/10.1007\/s12035-017-0636-x","journal-title":"Mol Neurobiol"},{"key":"4589_CR223","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbrc.2020.04.068","volume":"527","author":"SL Johnson","year":"2020","unstructured":"Johnson SL, Iannucci J, Seeram NP, Grammas P (2020) Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson\u2019s disease. Biochem Biophys Res Commun 527:532\u2013538. https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.068","journal-title":"Biochem Biophys Res Commun"},{"key":"4589_CR224","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnmol.2020.00114","volume":"13","author":"R Chen","year":"2020","unstructured":"Chen R, Cao X, Luo W et al (2020) Dabigatran suppresses PAR-1\/SphK\/S1P activation of astrocytes in experimental autoimmune encephalomyelitis model. Front Mol Neurosci 13:114. https:\/\/doi.org\/10.3389\/fnmol.2020.00114","journal-title":"Front Mol Neurosci"},{"key":"4589_CR225","doi-asserted-by":"publisher","unstructured":"Gray E, Hogwood J, Mulloy B (2012) The anticoagulant and antithrombotic mechanisms of heparin. Handb Exp Pharmacol 43\u201361. https:\/\/doi.org\/10.1007\/978-3-642-23056-1_3","DOI":"10.1007\/978-3-642-23056-1_3"},{"key":"4589_CR226","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1472-8206.2010.00845.x","volume":"25","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, L\u00fc T, Yuan H (2011) Neuroprotective effects of ultra-low-molecular-weight heparin in vitro and vivo models of ischemic injury. Fundam Clin Pharmacol 25:300\u2013303. https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00845.x","journal-title":"Fundam Clin Pharmacol"},{"key":"4589_CR227","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jcp.21465","volume":"216","author":"M Colombres","year":"2008","unstructured":"Colombres M, Henr\u00edquez JP, Reig GF et al (2008) Heparin activates Wnt signaling for neuronal morphogenesis. J Cell Physiol 216:805\u2013815. https:\/\/doi.org\/10.1002\/jcp.21465","journal-title":"J Cell Physiol"},{"key":"4589_CR228","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s0197-4580(02)00003-9","volume":"23","author":"L Bergamaschini","year":"2002","unstructured":"Bergamaschini L, Donarini C, Rossi E et al (2002) Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-beta in vitro. Neurobiol Aging 23:531\u2013536. https:\/\/doi.org\/10.1016\/s0197-4580(02)00003-9","journal-title":"Neurobiol Aging"},{"key":"4589_CR229","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/00003495-199244030-00010","volume":"44","author":"MM Buckley","year":"1992","unstructured":"Buckley MM, Sorkin EM (1992) Enoxaparin: a review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 44:465\u2013497","journal-title":"Drugs"},{"key":"4589_CR230","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.0550-04.2004","volume":"24","author":"L Bergamaschini","year":"2004","unstructured":"Bergamaschini L, Rossi E, Storini C et al (2004) Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer\u2019s disease. J Neurosci 24:4181\u20134186. https:\/\/doi.org\/10.1523\/JNEUROSCI.0550-04.2004","journal-title":"J Neurosci"},{"key":"4589_CR231","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.nbd.2010.06.008","volume":"40","author":"NM Timmer","year":"2010","unstructured":"Timmer NM, van Dijk L, van der Zee CEEM et al (2010) Enoxaparin treatment administered at both early and late stages of amyloid \u03b2 deposition improves cognition of APPswe\/PS1dE9 mice with differential effects on brain A\u03b2 levels. Neurobiol Dis 40:340\u2013347. https:\/\/doi.org\/10.1016\/j.nbd.2010.06.008","journal-title":"Neurobiol Dis"},{"key":"4589_CR232","doi-asserted-by":"publisher","first-page":"785459","DOI":"10.1155\/2011\/785459","volume":"2011","author":"H Kalanie","year":"2011","unstructured":"Kalanie H, Harandi AA, Alidaei S et al (2011) Venous thrombosis in multiple sclerosis patients after high-dose intravenous methylprednisolone: the preventive effect of enoxaparin. Thrombosis 2011:785459. https:\/\/doi.org\/10.1155\/2011\/785459","journal-title":"Thrombosis"},{"key":"4589_CR233","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"T-S Tang","year":"2005","unstructured":"Tang T-S, Slow E, Lupu V et al (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease. Proc Natl Acad Sci U S A 102:2602\u20132607. https:\/\/doi.org\/10.1073\/pnas.0409402102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4589_CR234","doi-asserted-by":"publisher","first-page":"660757","DOI":"10.3389\/fphar.2021.660757","volume":"12","author":"C Junren","year":"2021","unstructured":"Junren C, Xiaofang X, Huiqiong Z et al (2021) Pharmacological activities and mechanisms of hirudin and its derivatives - a review. Front Pharmacol 12:660757. https:\/\/doi.org\/10.3389\/fphar.2021.660757","journal-title":"Front Pharmacol"},{"key":"4589_CR235","doi-asserted-by":"publisher","first-page":"108967","DOI":"10.1016\/j.intimp.2022.108967","volume":"110","author":"W-Q Li","year":"2022","unstructured":"Li W-Q, Qin Z-S, Chen S et al (2022) Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: in vivo and in vitro approaches. Int Immunopharmacol 110:108967. https:\/\/doi.org\/10.1016\/j.intimp.2022.108967","journal-title":"Int Immunopharmacol"},{"key":"4589_CR236","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7150\/ijms.4363","volume":"9","author":"D Li","year":"2012","unstructured":"Li D, Zhou Y, Yang H (2012) Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer\u2019s disease: a 20-week open-label pilot study. Int J Med Sci 9:248\u2013255. https:\/\/doi.org\/10.7150\/ijms.4363","journal-title":"Int J Med Sci"},{"key":"4589_CR237","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature06559","volume":"451","author":"MH Han","year":"2008","unstructured":"Han MH, Hwang S-I, Roy DB et al (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451:1076\u20131081. https:\/\/doi.org\/10.1038\/nature06559","journal-title":"Nature"},{"key":"4589_CR238","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12974-017-0926-2","volume":"14","author":"L Stolz","year":"2017","unstructured":"Stolz L, Derouiche A, Devraj K et al (2017) Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis. J Neuroinflammation 14:152. https:\/\/doi.org\/10.1186\/s12974-017-0926-2","journal-title":"J Neuroinflammation"},{"key":"4589_CR239","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10286-017-0433-7","volume":"27","author":"A Mehdirad","year":"2017","unstructured":"Mehdirad A, Karabin B, Gupta F (2017) Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension. Clin Auton Res 27:25\u201327","journal-title":"Clin Auton Res"},{"issue":"10","key":"4589_CR240","doi-asserted-by":"publisher","first-page":"afad197","DOI":"10.1093\/ageing\/afad197","volume":"52","author":"K Kitt","year":"2023","unstructured":"Kitt K, Murphy R, Clarke A et al (2023) Antiplatelet therapy and incident cognitive impairment or dementia\u2014a systematic review and meta-analysis of randomised clinical trials. Age Ageing 52(10):afad197. https:\/\/doi.org\/10.1093\/ageing\/afad197","journal-title":"Age Ageing"},{"issue":"9","key":"4589_CR241","doi-asserted-by":"publisher","first-page":"e023918","DOI":"10.1161\/JAHA.121.023918","volume":"11","author":"J Ramos-Cejudo","year":"2022","unstructured":"Ramos-Cejudo J, Johnson AD, Beiser A et al (2022) Platelet function is associated with dementia risk in the Framingham Heart Study. J Am Heart Assoc 11(9):e023918. https:\/\/doi.org\/10.1161\/JAHA.121.023918","journal-title":"J Am Heart Assoc"},{"key":"4589_CR242","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/ATVBAHA.118.310955","volume":"39","author":"A Majithia","year":"2019","unstructured":"Majithia A, Bhatt DL (2019) Novel antiplatelet therapies for atherothrombotic diseases. Arterioscler Thromb Vasc Biol 39:546\u2013557. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310955","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4589_CR243","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1523\/JNEUROSCI.0054-18.2018","volume":"38","author":"S Chandra","year":"2018","unstructured":"Chandra S, Jana M, Pahan K (2018) Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer\u2019s disease via PPAR\u03b1. J Neurosci 38:6682\u20136699. https:\/\/doi.org\/10.1523\/JNEUROSCI.0054-18.2018","journal-title":"J Neurosci"},{"key":"4589_CR244","doi-asserted-by":"publisher","first-page":"E7408","DOI":"10.1073\/pnas.1802021115","volume":"115","author":"D Patel","year":"2018","unstructured":"Patel D, Roy A, Kundu M et al (2018) Aspirin binds to PPAR\u03b1 to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci U S A 115:E7408\u2013E7417. https:\/\/doi.org\/10.1073\/pnas.1802021115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4589_CR245","doi-asserted-by":"publisher","first-page":"e0252969","DOI":"10.1371\/journal.pone.0252969","volume":"16","author":"J Weng","year":"2021","unstructured":"Weng J, Zhao G, Weng L, Guan J (2021) Aspirin using was associated with slower cognitive decline in patients with Alzheimer\u2019s disease. PLoS ONE 16:e0252969. https:\/\/doi.org\/10.1371\/journal.pone.0252969","journal-title":"PLoS ONE"},{"key":"4589_CR246","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lfs.2016.02.072","volume":"154","author":"B Thrash-Williams","year":"2016","unstructured":"Thrash-Williams B, Karuppagounder SS, Bhattacharya D et al (2016) Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid. Life Sci 154:24\u201329. https:\/\/doi.org\/10.1016\/j.lfs.2016.02.072","journal-title":"Life Sci"},{"key":"4589_CR247","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11481-018-9808-3","volume":"14","author":"SB Rangasamy","year":"2019","unstructured":"Rangasamy SB, Dasarathi S, Pahan P et al (2019) Low-dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for Parkinson\u2019s disease. J Neuroimmune Pharmacol 14:173\u2013187. https:\/\/doi.org\/10.1007\/s11481-018-9808-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"4589_CR248","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.28189","volume":"35","author":"M San Luciano","year":"2020","unstructured":"San Luciano M, Tanner CM, Meng C et al (2020) Nonsteroidal <scp>anti-inflammatory<\/scp> Use and <scp> LRRK2 <\/scp> Parkinson\u2019s disease penetrance. Mov Disord 35:1755\u20131764. https:\/\/doi.org\/10.1002\/mds.28189","journal-title":"Mov Disord"},{"key":"4589_CR249","doi-asserted-by":"publisher","first-page":"18533","DOI":"10.1074\/jbc.M112.447268","volume":"288","author":"KK Modi","year":"2013","unstructured":"Modi KK, Sendtner M, Pahan K (2013) Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis. J Biol Chem 288:18533\u201318545. https:\/\/doi.org\/10.1074\/jbc.M112.447268","journal-title":"J Biol Chem"},{"key":"4589_CR250","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12916-015-0394-4","volume":"13","author":"S Tsau","year":"2015","unstructured":"Tsau S, Emerson MR, Lynch SG, LeVine SM (2015) Aspirin and multiple sclerosis. BMC Med 13:153. https:\/\/doi.org\/10.1186\/s12916-015-0394-4","journal-title":"BMC Med"},{"key":"4589_CR251","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/dna.2019.4814","volume":"38","author":"S Pahan","year":"2019","unstructured":"Pahan S, Pahan K (2019) Mode of action of aspirin in experimental autoimmune encephalomyelitis. DNA Cell Biol 38:593\u2013596. https:\/\/doi.org\/10.1089\/dna.2019.4814","journal-title":"DNA Cell Biol"},{"key":"4589_CR252","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.bpj.2015.01.014","volume":"108","author":"A Abdolvahabi","year":"2015","unstructured":"Abdolvahabi A, Shi Y, Rhodes NR et al (2015) Arresting amyloid with coulomb\u2019s law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation. Biophys J 108:1199\u20131212. https:\/\/doi.org\/10.1016\/j.bpj.2015.01.014","journal-title":"Biophys J"},{"key":"4589_CR253","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1089\/ars.2016.6978","volume":"27","author":"S Ayyadevara","year":"2017","unstructured":"Ayyadevara S, Balasubramaniam M, Kakraba S et al (2017) Aspirin-mediated acetylation protects against multiple neurodegenerative pathologies by impeding protein aggregation. Antioxid Redox Signal 27:1383\u20131396. https:\/\/doi.org\/10.1089\/ars.2016.6978","journal-title":"Antioxid Redox Signal"},{"key":"4589_CR254","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2165\/00003495-200666050-00009","volume":"66","author":"D Murdoch","year":"2006","unstructured":"Murdoch D, Plosker GL (2006) Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Drugs 66:671\u2013692. https:\/\/doi.org\/10.2165\/00003495-200666050-00009","journal-title":"Drugs"},{"key":"4589_CR255","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nbd.2010.01.019","volume":"38","author":"M Coma","year":"2010","unstructured":"Coma M, Seren\u00f3 L, Da Rocha-Souto B et al (2010) Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 38:482\u2013491. https:\/\/doi.org\/10.1016\/j.nbd.2010.01.019","journal-title":"Neurobiol Dis"},{"key":"4589_CR256","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainres.2010.10.008","volume":"1366","author":"SN Whitehead","year":"2010","unstructured":"Whitehead SN, Massoni E, Cheng G et al (2010) Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer\u2019s disease and stroke. Brain Res 1366:246\u2013256. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.008","journal-title":"Brain Res"},{"key":"4589_CR257","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/WAD.0b013e3181611024","volume":"22","author":"T G\u00f3mez-Isla","year":"2008","unstructured":"G\u00f3mez-Isla T, Blesa R, Boada M et al (2008) A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment. Alzheimer Dis Assoc Disord 22:21\u201329. https:\/\/doi.org\/10.1097\/WAD.0b013e3181611024","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4589_CR258","doi-asserted-by":"publisher","first-page":"8336","DOI":"10.1038\/s41598-019-44803-1","volume":"9","author":"EJR Fletcher","year":"2019","unstructured":"Fletcher EJR, Jamieson AD, Williams G et al (2019) Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats. Sci Rep 9:8336. https:\/\/doi.org\/10.1038\/s41598-019-44803-1","journal-title":"Sci Rep"},{"key":"4589_CR259","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2017.02.018","volume":"643","author":"S-W Kim","year":"2017","unstructured":"Kim S-W, Choi K-J, Park J-Y et al (2017) Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain. Neurosci Lett 643:59\u201364. https:\/\/doi.org\/10.1016\/j.neulet.2017.02.018","journal-title":"Neurosci Lett"},{"key":"4589_CR260","doi-asserted-by":"publisher","first-page":"788407","DOI":"10.3389\/fnagi.2022.788407","volume":"14","author":"D Pan","year":"2022","unstructured":"Pan D, Rong X, Li H et al (2022) Anti-platelet therapy is associated with lower risk of dementia in patients with cerebral small vessel disease. Front Aging Neurosci 14:788407. https:\/\/doi.org\/10.3389\/fnagi.2022.788407","journal-title":"Front Aging Neurosci"},{"key":"4589_CR261","doi-asserted-by":"publisher","first-page":"ra52","DOI":"10.1126\/scisignal.aaf6240","volume":"9","author":"L Donner","year":"2016","unstructured":"Donner L, F\u00e4lker K, Gremer L et al (2016) Platelets contribute to amyloid-\u03b2 aggregation in cerebral vessels through integrin \u03b1IIb\u03b23-induced outside-in signaling and clusterin release. Sci Signal 9:ra52. https:\/\/doi.org\/10.1126\/scisignal.aaf6240","journal-title":"Sci Signal"},{"key":"4589_CR262","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.26032","volume":"89","author":"MS Andersen","year":"2021","unstructured":"Andersen MS, Bandres-Ciga S, Reynolds RH et al (2021) Heritability enrichment implicates microglia in Parkinson\u2019s disease pathogenesis. Ann Neurol 89:942\u2013951. https:\/\/doi.org\/10.1002\/ana.26032","journal-title":"Ann Neurol"},{"key":"4589_CR263","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/TCRM.S152369","volume":"14","author":"MJ Kubisa","year":"2018","unstructured":"Kubisa MJ, Jezewski MP, Gasecka A et al (2018) Ticagrelor - toward more efficient platelet inhibition and beyond. Ther Clin Risk Manag 14:129\u2013140. https:\/\/doi.org\/10.2147\/TCRM.S152369","journal-title":"Ther Clin Risk Manag"},{"key":"4589_CR264","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/jcbfm.2014.45","volume":"34","author":"P Gelosa","year":"2014","unstructured":"Gelosa P, Lecca D, Fumagalli M et al (2014) Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J Cereb Blood Flow Metab 34:979\u2013988. https:\/\/doi.org\/10.1038\/jcbfm.2014.45","journal-title":"J Cereb Blood Flow Metab"},{"key":"4589_CR265","doi-asserted-by":"publisher","first-page":"12088","DOI":"10.1038\/s41598-017-12205-w","volume":"7","author":"K Yamauchi","year":"2017","unstructured":"Yamauchi K, Imai T, Shimazawa M et al (2017) Effects of ticagrelor in a mouse model of ischemic stroke. Sci Rep 7:12088. https:\/\/doi.org\/10.1038\/s41598-017-12205-w","journal-title":"Sci Rep"},{"key":"4589_CR266","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijcard.2022.01.060","volume":"353","author":"X Li","year":"2022","unstructured":"Li X, Jia Z, Yan Y (2022) Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: a meta-analysis of randomized controlled trials. Int J Cardiol 353:96\u2013102. https:\/\/doi.org\/10.1016\/j.ijcard.2022.01.060","journal-title":"Int J Cardiol"},{"key":"4589_CR267","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4049\/jimmunol.1601549","volume":"199","author":"C Qin","year":"2017","unstructured":"Qin C, Zhou J, Gao Y et al (2017) Critical role of P2Y(12) receptor in regulation of Th17 differentiation and experimental autoimmune encephalomyelitis pathogenesis. J Immunol 199:72\u201381. https:\/\/doi.org\/10.4049\/jimmunol.1601549","journal-title":"J Immunol"},{"key":"4589_CR268","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4049\/jimmunol.0903480","volume":"185","author":"E-J Lee","year":"2010","unstructured":"Lee E-J, Woo M-S, Moon P-G et al (2010) Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185:615\u2013623. https:\/\/doi.org\/10.4049\/jimmunol.0903480","journal-title":"J Immunol"},{"key":"4589_CR269","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00213-021-05798-8","volume":"238","author":"D Zare","year":"2021","unstructured":"Zare D, Rajizadeh MA, Maneshian M et al (2021) Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer\u2019s diseases. Psychopharmacology 238:1645\u20131656. https:\/\/doi.org\/10.1007\/s00213-021-05798-8","journal-title":"Psychopharmacology"},{"key":"4589_CR270","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0304-3940(02)00043-5","volume":"320","author":"J Rodr\u00edguez-Pallares","year":"2002","unstructured":"Rodr\u00edguez-Pallares J, Caruncho HJ, Guerra MJ, Labandeira-Garc\u00eda JL (2002) Dipyridamole-induced increase in production of rat dopaminergic neurons from mesencephalic precursors. Neurosci Lett 320:65\u201368. https:\/\/doi.org\/10.1016\/s0304-3940(02)00043-5","journal-title":"Neurosci Lett"},{"key":"4589_CR271","doi-asserted-by":"publisher","first-page":"11469","DOI":"10.1038\/s41598-017-11664-5","volume":"7","author":"M H\u00f6llerhage","year":"2017","unstructured":"H\u00f6llerhage M, Moebius C, Melms J et al (2017) Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Sci Rep 7:11469. https:\/\/doi.org\/10.1038\/s41598-017-11664-5","journal-title":"Sci Rep"},{"key":"4589_CR272","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/092986712803414240","volume":"19","author":"A Tello-Montoliu","year":"2012","unstructured":"Tello-Montoliu A, Jover E, Rivera J et al (2012) New perspectives in antiplatelet therapy. Curr Med Chem 19:406\u2013427. https:\/\/doi.org\/10.2174\/092986712803414240","journal-title":"Curr Med Chem"},{"key":"4589_CR273","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJD Daniels","year":"2016","unstructured":"Daniels MJD, Rivers-Auty J, Schilling T et al (2016) Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat Commun 7:12504. https:\/\/doi.org\/10.1038\/ncomms12504","journal-title":"Nat Commun"},{"key":"4589_CR274","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh SE, Abud EM, Lakatos A et al (2016) The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A 113:E1316\u2013E1325. https:\/\/doi.org\/10.1073\/pnas.1525466113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4589_CR275","doi-asserted-by":"publisher","first-page":"100619","DOI":"10.1016\/j.blre.2019.100619","volume":"39","author":"D Swan","year":"2020","unstructured":"Swan D, Loughran N, Makris M, Thachil J (2020) Management of bleeding and procedures in patients on antiplatelet therapy. Blood Rev 39:100619. https:\/\/doi.org\/10.1016\/j.blre.2019.100619","journal-title":"Blood Rev"},{"issue":"S1","key":"4589_CR276","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1002\/ajh.23165","volume":"87","author":"KA Bauer","year":"2012","unstructured":"Bauer KA (2012) Reversal of antithrombotic agents. Am J Hematol 87(S1):S119\u2013S126. https:\/\/doi.org\/10.1002\/ajh.23165","journal-title":"Am J Hematol"},{"key":"4589_CR277","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000495425","volume":"26","author":"P Hundehege","year":"2018","unstructured":"Hundehege P, Fernandez-Orth J, R\u00f6mer P et al (2018) Targeting voltage-dependent calcium channels with pregabalin exerts a direct neuroprotective effect in an animal model of multiple sclerosis. Neurosignals 26:77\u201393. https:\/\/doi.org\/10.1159\/000495425","journal-title":"Neurosignals"},{"issue":"11","key":"4589_CR278","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3390\/antiox10111671","volume":"10","author":"BK Lee","year":"2021","unstructured":"Lee BK, Jee HJ, Jung Y-S (2021) A\u03b2(1\u201340)-induced platelet adhesion is ameliorated by rosmarinic acid through inhibition of NADPH oxidase\/PKC-\u03b4\/integrin \u03b1(IIb)\u03b2(3) signaling. Antioxidants (Basel) 10(11):1671. https:\/\/doi.org\/10.3390\/antiox10111671","journal-title":"Antioxidants (Basel)"},{"key":"4589_CR279","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jpsychires.2013.01.014","volume":"47","author":"R Wang","year":"2013","unstructured":"Wang R, Jin D, Li Y, Liang Q (2013) Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer\u2019s disease. J Psychiatr Res 47:644\u2013649. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.01.014","journal-title":"J Psychiatr Res"},{"key":"4589_CR280","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/09537104.2013.831064","volume":"25","author":"Q-C Liang","year":"2014","unstructured":"Liang Q-C, Jin D, Li Y, Wang R-T (2014) Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer\u2019s disease. Platelets 25:433\u2013438. https:\/\/doi.org\/10.3109\/09537104.2013.831064","journal-title":"Platelets"},{"key":"4589_CR281","unstructured":"Simonidze V, Samushia O (2014) [Comparative analysis of structural changes in thrombocytes during Alzheimer\u2019s and Parkinson\u2019s diseases]. Georgian Med News 41\u201346"},{"key":"4589_CR282","doi-asserted-by":"publisher","first-page":"15483","DOI":"10.1038\/s41598-018-33768-2","volume":"8","author":"KM Kniewallner","year":"2018","unstructured":"Kniewallner KM, Foidl BM, Humpel C (2018) Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model. Sci Rep 8:15483. https:\/\/doi.org\/10.1038\/s41598-018-33768-2","journal-title":"Sci Rep"},{"key":"4589_CR283","doi-asserted-by":"publisher","first-page":"986254","DOI":"10.1155\/2013\/986254","volume":"2013","author":"A Ko\u00e7er","year":"2013","unstructured":"Ko\u00e7er A, Yaman A, Niftaliyev E et al (2013) Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson\u2019s disease. Curr Gerontol Geriatr Res 2013:986254. https:\/\/doi.org\/10.1155\/2013\/986254","journal-title":"Curr Gerontol Geriatr Res"},{"key":"4589_CR284","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0304-3940(93)90216-8","volume":"163","author":"NC Inestrosa","year":"1993","unstructured":"Inestrosa NC, Alarc\u00f3n R, Arriagada J et al (1993) Platelet of Alzheimer patients: increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine. Neurosci Lett 163:8\u201310. https:\/\/doi.org\/10.1016\/0304-3940(93)90216-8","journal-title":"Neurosci Lett"},{"issue":"643","key":"4589_CR285","doi-asserted-by":"publisher","first-page":"eaba9872","DOI":"10.1126\/scisignal.aba9872","volume":"13","author":"L Donner","year":"2020","unstructured":"Donner L, Toska LM, Kr\u00fcger I et al (2020) The collagen receptor glycoprotein VI promotes platelet-mediated aggregation of \u03b2-amyloid. Sci Signal 13(643):eaba9872. https:\/\/doi.org\/10.1126\/scisignal.aba9872","journal-title":"Sci Signal"},{"key":"4589_CR286","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/09537104.2017.1401057","volume":"29","author":"O Elaskalani","year":"2018","unstructured":"Elaskalani O, Khan I, Morici M et al (2018) Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI. Platelets 29:415\u2013420. https:\/\/doi.org\/10.1080\/09537104.2017.1401057","journal-title":"Platelets"},{"issue":"12","key":"4589_CR287","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.3390\/ijms22126572","volume":"22","author":"A Dziedzic","year":"2021","unstructured":"Dziedzic A, Miller E, Saluk-Bijak J et al (2021) The molecular aspects of disturbed platelet activation through ADP\/P2Y(12) pathway in multiple sclerosis. Int J Mol Sci 22(12):6572. https:\/\/doi.org\/10.3390\/ijms22126572","journal-title":"Int J Mol Sci"},{"key":"4589_CR288","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3389\/fneur.2018.01175","volume":"9","author":"D Plantone","year":"2018","unstructured":"Plantone D, Inglese M, Salvetti M, Koudriavtseva T (2018) A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis. Front Neurol 9:1175. https:\/\/doi.org\/10.3389\/fneur.2018.01175","journal-title":"Front Neurol"},{"key":"4589_CR289","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0022-510x(94)90056-6","volume":"122","author":"SA Factor","year":"1994","unstructured":"Factor SA, Ortof E, Dentinger MP et al (1994) Platelet morphology in Parkinson\u2019s disease: an electron microscopic study. J Neurol Sci 122:84\u201389. https:\/\/doi.org\/10.1016\/0022-510x(94)90056-6","journal-title":"J Neurol Sci"},{"key":"4589_CR290","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1042\/BST20170291","volume":"45","author":"L Wang","year":"2017","unstructured":"Wang L, Wu Q, Fan Z et al (2017) Platelet mitochondrial dysfunction and the correlation with human diseases. Biochem Soc Trans 45:1213\u20131223. https:\/\/doi.org\/10.1042\/BST20170291","journal-title":"Biochem Soc Trans"},{"key":"4589_CR291","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2008.01.004","volume":"57","author":"M-Y Shen","year":"2008","unstructured":"Shen M-Y, Hsiao G, Fong T-H et al (2008) Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase Cgamma2-protein kinase C pathway in platelet activation. Pharmacol Res 57:151\u2013158. https:\/\/doi.org\/10.1016\/j.phrs.2008.01.004","journal-title":"Pharmacol Res"},{"key":"4589_CR292","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2020.00129","volume":"14","author":"KM Kniewallner","year":"2020","unstructured":"Kniewallner KM, de Sousa DMB, Unger MS et al (2020) Platelets in amyloidogenic mice are activated and invade the brain. Front Neurosci 14:129. https:\/\/doi.org\/10.3389\/fnins.2020.00129","journal-title":"Front Neurosci"},{"key":"4589_CR293","doi-asserted-by":"publisher","unstructured":"Muriu RG, Sage JM, Agbas A (2019) Platelet proteolytic machinery assessment in Alzheimer\u2019s diseases. bioRxiv 760116. https:\/\/doi.org\/10.1101\/760116","DOI":"10.1101\/760116"},{"issue":"16","key":"4589_CR294","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.3390\/ijms21165869","volume":"21","author":"SH Lee","year":"2020","unstructured":"Lee SH, Du J, Hwa J, Kim W-H (2020) Parkin coordinates platelet stress response in diabetes mellitus: a big role in a small cell. Int J Mol Sci 21(16):5869. https:\/\/doi.org\/10.3390\/ijms21165869","journal-title":"Int J Mol Sci"},{"key":"4589_CR295","doi-asserted-by":"publisher","unstructured":"Plagg B, Humpel C (2015) Platelets in Alzheimer\u2019s disease. The non-thrombotic role of platelets in health and disease. https:\/\/doi.org\/10.5772\/60535","DOI":"10.5772\/60535"},{"key":"4589_CR296","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1124\/jpet.107.122853","volume":"322","author":"MR Marwali","year":"2007","unstructured":"Marwali MR, Hu C-P, Mohandas B et al (2007) Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther 322:1324\u20131332. https:\/\/doi.org\/10.1124\/jpet.107.122853","journal-title":"J Pharmacol Exp Ther"},{"key":"4589_CR297","doi-asserted-by":"publisher","first-page":"172956","DOI":"10.1016\/j.pbb.2020.172956","volume":"195","author":"NEA Khalaf","year":"2020","unstructured":"Khalaf NEA, El Banna FM, Youssef MY et al (2020) Clopidogrel combats neuroinflammation and enhances learning behavior and memory in a rat model of Alzheimer\u2019s disease. Pharmacol Biochem Behav 195:172956. https:\/\/doi.org\/10.1016\/j.pbb.2020.172956","journal-title":"Pharmacol Biochem Behav"},{"key":"4589_CR298","doi-asserted-by":"publisher","first-page":"e002889","DOI":"10.1161\/JAHA.115.002889","volume":"5","author":"K Ohno","year":"2016","unstructured":"Ohno K, Tomizawa A, Mizuno M et al (2016) Prasugrel, a platelet P2Y12 receptor antagonist, improves abnormal gait in a novel murine model of thrombotic hindlimb ischemia. J Am Heart Assoc 5:e002889. https:\/\/doi.org\/10.1161\/JAHA.115.002889","journal-title":"J Am Heart Assoc"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04589-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04589-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04589-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:07:38Z","timestamp":1741082858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04589-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":298,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4589"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04589-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that this study does not involve any human participants. The images and illustrations were created using the \u201cMind the Graph\u201d platform provided\/licensed under Editage and \u201cServier Medical Art,\u201d provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license. Figure\u00a0\u00a0contains a few cartoon\/artificial human-like illustrations representing various NDD patients and medical staffs; therefore, any resemblance to potential human faces is purely coincidental.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}